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ABSTRACT 
The multifunctional mammalian apurinic/apyrimidinic (AP) 
endonuclease is responsible for the repair of AP sites in DNA. 
Apurinic and apyrimidinic sites are among the most common DNA 
lesions and can lead to polymerase halting, and, therefore, 
aberrant transcripts and even cell death. Consequentially, AP 
endonucleases have a critical role in the maintenance of DNA 
integrity and cell survival. This type of lesion results from 
the hydrolysis of the glycosylic bond between the base and 
deoxyribose and may occur through a variety of mechanisms 
including the following: First, AP sites can be produced by the 
effects of ionizing radiation and by oxidative agents that are 
the by-products of biological processes such as oxidative 
respiration of aerobic organisms, superoxide generation by 
activated macrophages and other immune cells, and by 
radiomimetic agents such as bleomycin. Second, these sites are 
the product of DNA N-glycosylases which recognize and catalyze 
the removal of damaged and incorrect bases from DNA. And third, 
spontaneous hydrolysis of the glycosylic bond occurs at a 
substantial rate: approximately 10, 000 bases are l.ost per cell 
per day making this one of the most predominant forms of DNA 
damage. 
xiii 
Currently, little is known about the regulation and 
expression of mammalian AP endonucleases. Previous studies 
examining the tissue specific distribution of the AP 
endonuclease transcript and protein by Northern analysis and 
enzymatic assays, respectively, indicated that this gene is 
expressed in all tissues at re la ti vely similar levels. The 
studies in this dissertation were designed to determine the 
developmental and cell specific pattern of expression of the rat 
and human AP endonuclease in vivo. 
By utilizing direct techniques such as 
immunohistochemistry and in situ hybridization, the expression 
of mammalian AP endonucleases was demonstrated to be highly 
differential within various tissues and cell types and during 
the developmental process. These results allow us to begin to 
understand the regulatory and functional relationships of the AP 
gene products to the different subtissue cell types. 
xiv 
CHAPTER I 
INTRODUCTION 
The inherent chemical instability of DNA, the production 
of reactive oxygen species during normal cellular metabolism 
(Demple and Harrison 1994), and the continuous exposure to 
environmental mutagens represent a potential threat to the 
genetic information of cells (Friedberg, 1985; Larson et al., 
1985; Loeb and Preston, 1986; Saffhil et al., 1985). If 
unrepaired, damaged DNA can have deleterious biological 
consequences for the organism and result in cell transformation 
or death (Friedberg, 1985). Thus, to protect against DNA 
damage, organisms have evolved an elaborate array of DNA repair 
mechanisms such as nucleotide excision repair (NER), 
mismatch/recombination repair and DNA base excision repair (BER) 
(Barnes et al., 1993; Lindahl, 1992; Lindahl, 1994). 
DNA base excision repair involves two major classes of 
repair enzymes, namely DNA glycosylases and 
apurinic/apyrimidinic (AP) endonucleases (Demple and Harrison, 
1994; Doetsch and Cunningham, 1990; Lindahl, 1992; Sancar and 
Sancar, 1988). DNA glycosylases are enzymes that hydrolyze the 
N-glycosidic bond between the damaged base and the deoxyribose 
moiety, leaving behind an AP site on the DNA backbone (Demple 
and Harrison, 1994; Doetsch and .Cunningham, 1990; Wallace, 
1988) • Cytotoxic lesions such as N3-methyladenine, 
methylguanine, and N3-methylguanine, are all released by the N-
methylpurine DNA glycosylase (MPG) enzyme (Mitra and Kaina, 
1993; Sakumi and Sekiguchi, 1990; Sancar and Sancar, 1988). AP 
sites prodQced by the action of N-glycosylases are acted upon by 
AP endonucleases, which can make an incision either 3' to the AP 
site (class I AP lyase) or 5' to the AP site (class II AP 
endonuclease) (Demple and Harrison, 1994; Doetsch and 
Cunningham, 1990). Furthermore, tens of thousands of AP sites 
are produced per cell per day, primarily by spontaneous base 
hydrolysis, and cellular metabolites reacting with oxygen 
radicals (Lindahl, 1993) .· Unrepaired AP sites bypassed during 
DNA replication result in mutations and genetic instability 
(Loeb and Preston, 1986). 
The major cellular enzymes initiating repair of AP sites 
("class II" AP endonucleases) have been identified and 
characterized in bacteria, yeast, Drosophila and mammals (Demple 
and Harrison, 1994; Demple et al., 1991; Doetsch and Cunningham, 
1990). 
backbone 
These repair 
immediately 5' 
deoxyribose-5-phosphate 
proteins 
to an 
which 
hydrolyze the phosphodiester 
AP site generating an abasic 
is released by a 5'-
deoxyribophosphodiesterase (dRPase) or .5' -exonuclease followed 
by DNA synthesis and ligation. These enzymes. have also been 
shown to contain repair activity for 3'-terminal oxidative 
lesions (Demple and Harrison 199.4; Demple et al., 1986; Henner 
et al., 1983; Ramotar et al., 1991). By hydrolyzing 3'-blocking 
3 
fragments from oxidized DNA, these enzymes can produce normal 
3'-hydroxyl nucleotide termini, permitting DNA repair synthesis.· 
Recently, the human AP endonuclease (hAPE) repair enzyme 
has been found to display multiple functions. Besides AP site 
DNA repair activity, hAPE potentiates the binding of Jun-Jun 
homodimers or Fos-Jun heterodimers to DNA by alternating the 
redox state of these proteins (Walker et al., 1993; Xanthoudakis 
and Curran, 1992; Xanthoudakis et al., 1992; Xanthoudakis et 
al., 1994; Yao et al., 1994). Hypoxic conditions in cell lines 
have been shown to increase AP endonuclease mRNA levels (Walker 
et al., 1994; Yao et al., 1994). AP endonuclease expression has 
recently been shown to be modulated in epithelium in a pig 
wound-healing model (Harrison et al., 1995). 
Currently our knowledge of the sites of AP endonuclease 
expression are limited. Northern analysis studies have shown 
that this gene is expressed in all tissues, albeit at 
relatively similar levels. Little, however, is known about 
whether this gene is differentially expressed in spe~ific 
subpopulations of cells or differentially during development. 
Bleomycin, a glycopeptide antibiotic, has been useful as a 
anti-tumor agent in the treatment of a number of neoplasms. The 
cytotoxic effect of this agent has been determined to be th.tough 
DNA damage (Harrison and Lazo, 1987) . A side effect of the 
clinical use of bleomycin is.pulmonary fibrosis which is thought 
to be induced by the DNA damaging action of bleomycin (Lazo and 
Sebti, 1991; Harrison et al., 1989). It has been demonstrated 
4 
that "activated" bleomycin reacts with the C-4' position of the 
sugar residue generating a 4'-oxidized AP site along with strand 
breaks (Hecht, 1986). Additionally, 4'-oxidized AP sites have 
been shown to be an excellent substrate for endonuclease IV 
requiring 4-fold lower concentrations of the protein than for 
recognition of regular AP sites (Haring et al., 1994). These 
results indicate that the base excision repair pathway, and AP 
endonuclease IV in particular, is involved in the repair of 
bleomycin induced 4' oxidized AP sites. 
The purpose of my dissertation research is to determine 
the developmental, tissue and sub-tissue specific expression of 
the major mammalian class II AP endonuclease. This will be 
accomplished utilizing in vivo methods of examination such as 
immunohistochemistry and in situ hybridization. Additionally, 
studies will be initiated on the ability of AP endonucleases to 
protect mammalian cells from the cell-killing effects of various 
chemotherapeutic agents including bleomycin. 
The significance of these studies is two fold. First, 
these experiments allow us to begin to understand the regulatory 
and functional relationships of the AP gene products to the 
different subtissue cell types. And second, 
normal cells from the cell-killing effects 
contribute significantly to future 
the protection of 
of bleomycin will 
studies on the 
prevention/treatment of bleomycin induced fibrotic lung disease. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
All organisms are continually subjected to DNA damaging 
agents, both endogenous and exogenous, which can lead to the 
disruption of RNA and DNA synthesis, cell killing, and, in the 
case of eukaryotes, aging and carcinogenesis. Of course, the 
ultimate effect of any DNA damage on an organism' s viability 
depends upon the type and location of the damage within the DNA 
and the efficiency with which it is repaired (see Friedberg, 
1985, for a comprehensive review of DNA damage and repair). In 
this chapter, the base excision DNA repair pathway will be 
discussed with an emphasis on mammalian AP endonucleases. 
A. DNA Damage and Repair Mechanisms 
DNA, being a highly reactive molecule, is the target of a 
wide variety of physical and chemical agents. Bases can be 
deaminated by heat and lost spontaneously or by the action of 
DNA-glycosylases; ionizing radiation can result in base 
fragmentation, ring opening, and single and double strand 
breaks; ultraviolet radiation produces pyrimidine dimers and 6-4 
photoproducts (Sancar and Sancar, 1988). Additionally, DNA can 
be modified by the action of agents such as methyl methane 
5 
6 
sulfonate (MMS) and the endogenous s-adenosyl methionine and by 
cross-linking agents such as cisplatin. However, one of the 
major sources of damage that DNA is exposed to on a daily basis 
are oxidative free radicals. These free radicals are the by 
products of biological processes such as oxidative respiration 
of aerobic organisms, superoxide generation by activated 
macrophages and other immune cells, and by radiomimetic agents 
such as bleomycin (Demple and Harrison, 1994). In fact, it has 
been determined that nearly 100 different types of free radical 
damage can occur (von Sonntag, 1987; Dizdaroglu, 1992). 
To cope with the production of DNA damage, cells have 
evolved a complex array of DNA repair mechanisms. Direct 
methods of repair exist that simply reverse the covalent 
modifications of DNA. Examples include DNA photolyase (Sancar, 
1994), an enzyme that catalyzes the breaking of the cyclobutane 
ring joining pyrimidines utilizing energy in light, and 0 6-mGua 
DNA methyltransferase (MGMT) (Mitra and Kaina, 1993), a protein 
that stoichiometrically transfers alkyl groups from the 0 6 
position of guanine in DNA to a cysteine residue in its 
structure. 
The excision repair pathways correct damaged DNA relying 
on the complementary strand for sequence information to repair 
the DNA duplex. In long patch repair, also referred to as 
nucleotide excision repair (NER), damaged bases are removed from 
DNA as an oligonucleotide of 27-29 bases (Huang et al., 1992). 
This pathway is the principal mechanism for removing bulky 
7 
adducts from DNA that have been induced by UV and cross-linking 
agents. The human NER pathway has been extremely well 
characterized and has recently been reconstituted in vitro in a 
reaction that 
(Aboussekhra et 
required approximately 
al., 1995). Short patch 
30 polypeptides 
repair, or base 
excision repair (BER), is responsible for the removal of unusual 
or modified bases and the repair of apurinic/apyrimidinic (AP) 
sites. During the repair of modified bases, the base is removed 
by hydrolysis of the glycosylic bond resulting in a single 
nucleotide gap that is filled in without nick translation 
(Doetsch and Cunningham, 1990). 
B. Apurinic/Apyrimidinic Sites 
One of the most prominent types of DNA damage is 
apurinic/apyrimidinic (AP) sites. This type of lesion results 
from the hydrolysis of the glycosylic bond between the base and 
deoxyribose and may occur through a variety of mechanisms. 
First, spontaneous hydrolysis of the glycosylic bond occurs at a 
substantial rate: approximately 10,000 bases are lost per cell 
per day (Ames, 1989;. Lindahl et al., 1972). Second, AP sites 
can be produced by the effects of oxidative agents and ionizing 
radiation which lead to ring opening increasing the lability of 
the glycosylic bond (Friedberg, 1985). And third, these sites 
are the product of DNA N-glycosylases which recognize and 
catalyze the removal of damaged and incorrect bases from DNA 
(Sakumi et al., 1990). While this list is not all inclusive, 
8 
these three mechanisms represent the major routes to the 
production of AP sites, the central intermediate in the base 
excision DNA repair pathway. 
c. Base Excision DNA Repair 
As previously mentioned, this repair pathway is 
responsible for the repair of damaged bases and AP sites. BER 
is the most highly conserved pathway from bacteria to humans 
denoting its importance in the maintenance of genetic integrity 
(Olsen et al., 1989; Demple et al., 1991). The general steps of 
this pathway include the recognition and release of the modified 
base by a specific N-glycoslyase followed by cleavage of the DNA 
phosphodiester backbone by an AP endonuclease or lyase. If 
necessary, blocking groups are removed by the action of either a 
deoxyribophosphodiesterase or a class II AP endonuclease. Next, 
the resulting gap is filled in by DNA polymerase and the nick 
sealed by DNA ligase (Figure 1). 
1 . DNA glycosylases 
These are small enzymes (20-45 kDa) that act first within the 
BER pathway in the removal of modified or incorrect bases from DNA 
by hydrolyzing the N-glycosylic bond between the deoxyribose and 
the base. This action results in the production of an 
apurinic/apyrimidinic site. A variety of DNA glycosylases have 
been isolated from both prokaryotic and eukaryotic organisms. 
These include thymine glycol glycosylases (Demple and Linn,· 1980), 
• 
BASE 
EXCISION REPAIR 
Base defect 
•••••••• •••••••• I Base removal 
t hy glycosylue 
••• • ••• •••••••• I Incision hy AP 
t endonuclease 
111.1111 
I Excision &. 
t polymerization 
•••••••• •••••••• + Ligation 
•••••••• •••••••• 
Figure 1. Schematic of base excision repair. This figure 
illustrates the general steps of base excision repair. 
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hypoxanthine-DNA glycosylase (Karran and Lindahl, 1980; Myrnes et 
al., 1982), and formamidopyrimidine-DNA glycosylase (Lindahl, 
1982; Bioteux et al., 1987). The major and best characterized DNA 
glycosylases, 3-methyladenine-DNA glycosylase and uracil-DNA 
glycosylase, are describe below. 
3-methyladenine (3-mAde), 7-methylguanine (7-mG), 
methylguanine (06-mG) and other alkylated bases are produced by 
exogenous alkylating agents such as N-methyl-N'-nitro-N-
nitrosoguanidine (MNNG), N-methyl-N-nitrosourea (MNU) and 
methylmethane sulfonate (MMS). Additionally, the endogenous S~ 
adenosylmethionine methylates DNA at a slow but significant rate 
producing 3-mAde and 7-mG (Saffhill et al., 1985). The 
generation of these alkyl adducts has been well characterized 
and shown to be highly mutagenic: especially 3-mAde, which, if 
not repaired, can block DNA replication (Lindahl et al., 1988). 
N-glycosylases which remove 3-mAde have been isolated and cloned 
from a variety of organisms. The two methyl purine DNA-
glycosylases (MPGs), Tag I and Tag II from E. coli have been 
studied in the greatest detail. 
The Tag I enzyme, encoded by the tag gene, is composed of 
187 amino acids with a molecular weight of 21 kDa (Sakumi et 
al., 1986). This enzyme has been shown to excise 3-mAde and 3""'." 
ethylAde from methylated DNA and is inhibited by the reaction 
product 3-mAde; however, it is not active on other alkylated 
bases. Mutants lacking this enzyme are moderately sensi~ive to 
MMS and other alkylating agents (Friedberg, 1985). 
f 
' 
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Additionally, expression of this gene does not depend on 
treatments that lead to the SOS or adaptive response and is, 
therefore, considered to be constitutive (Sakumi et al., 1990). 
The Tag II enzyme is encoded by the alkA gene and consists 
of 282 amino acids molecular weight of 31.4 kDa. This enzyme 
removes 3-m.Ade and 3-mG from DNA with equal efficiency, and 7-
m.Ade, 7-mG, and 0 2-methylpyrimidines at slower rates (Thomas et 
al., 1982). Unlike Tag I, this enzyme is not inhibited by free 
3-m.Ade. Furthermore wild type E. coli treated (adapted) with 
alkylating agents show a dramatic increase in the number of Tag 
II molecules, and alkA- mutants are highly sensitive to MMS and 
MNNG (Sakumi et al., 1990) indicating the importance of this 
enzyme in the repair of alkylated bases. The sequences of Tag I 
and Tag II reveal no significant homology reflecting differences 
in substrate specificity and, perhaps, mechanisms of action. 
MPGs have been detected in, and cloned from, a wide 
variety of mammalian sources including rodents, bovine and human 
(O'Connor et al., 1990; Engelward et al., 1993; Male et al., 
1985; Chakravarti, et al., 1991). These mammalian MPGs appear 
to be similar to the E. coli Tag II in that they have 
significant sequence similarity, are similar in molecular 
weight, and possess broad substrate specificity (O'Connor et 
al., 1990). However, very little is currently known about the 
expression and regulation of this enzyme in mammals. Mitra and 
co-workers have published on the age-dependent modulation of 
12 
tissue-specific activity of 3-mAde-DNA glycosylase in female 
mice (Washington et al., 1989). They noted that, in addition to 
differences in the enzyme levels between two stocks of mice for 
each organ examined, suckling animals (9 day old) have 
consistently lower levels of MPG than young adults (7-8 weeks 
old) . Furthermore, MPG levels in adults ( 15-17 months) were 
significantly lower than those in young adults indicating an 
age-dependent modulation of MPG in female mice. Additionally, 
the level of MPG activity in the rat hepatoma cell line (H4) has 
been shown to increase after both single and repeated exposures 
to DNA damaging agents (O'Connor et al., 1990). While this 
increase is not an adaptive response, it does suggest that MPG 
activity is inducible by DNA damage in rat liver cells. This 
response has not been observed in other mammals. Studies on the 
molecular mechanisms of MPG regulation are currently underway. 
Uracil-DNA glycosylases, UDG, have been isolated from a 
number of organisms including E. coli (Varshney et al., 1988), 
herpes virus (Worrad and Caradonna, 1988) yeast (Percival et 
al., 1989) and humans (Olsen, et al., 1989; Wittwer et al., 
1989; Muller and Caradonna, 1991). Uracil can arise in DNA by a 
variety of mechanisms: by mis-incorporation by a DNA 
polymerase, by spontaneous deamination of cytosine, by bisulfite 
and nitrous acid deamination of cytosine, and by DNA-(cytosine-
5)-methyltransferases (Lindahl, 1994; Friedberg, 1985; Sancar 
and Sancar, 1988; Shen et al., 1992). Additionally, nitric 
oxide, a constituent of cigarette smoke has been shown to 
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greatly accelerate the deamination of cytosine (Wink et al. , 
1991). The incorporation of uracil or the deamination of 
cytosine results in a pre-mutagenic U:G mismatch that will cause 
a GC to AT transition mutation if left un-repaired. E. coli 
mutants for the ung gene display a 5 to 30 fold increase in the 
spontaneous mutation rate (Duncan and Weiss, 1982) while yeast 
ung mutants show a 20-fold increase in spontaneous mutations 
(Impellizzeri et al., 1991). 
All human tissues examined have been found to posses 
uracil-DNA glycosylase activity (Krokan et al., 1983; Myrnes et 
al., 1983). To date, three different uracil-DNA glycosylases 
have been characterized. A 26 kDa glycosylase was isolated from 
human placental cells that showed significant homology to the 
uracil-DNA glycosylases, ung genes, isolated from E. coli, yeast 
and herpes virus (Olsen et al., 1989). In fact, the human 
protein showed the highest similarity to the E. coli protein 
with 73% similarity when conservative amino acid substitutions 
were included. Cell cycle analysis of this gene's transcripts 
revealed an 8-12 fold increase in transcript levels during Gl 
phase with a 2-3 fold increase in total enzyme activity in the 
S-phase indicating that this gene is cell cycle regulated 
(Slupphaug et al., 1991). The ung gene promoter was determined 
to posses an E2F element that is involved in the cell cycle 
regulation of a number of genes (Nevins, 1992). 
A second uracil-DNA glycosylase of 36 kDa was isolated 
that shows significant homology to the cyclin protein family 
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(Muller and Caradonna, 1993). This gene was also demonstrated 
to be cell cycle regulated with 2-3 fold elevation of transcript 
levels at Gl phase with a subsequent rise in protein levels 
during S-phase. Kinetic analysis of the mRNA and protein 
induction suggested that expression of this gene is controlled 
by a repression mechanism (Muller and Caradonna, 1993). 
A third uracil-DNA glycosylase was isolated from a human 
placental library utilizing monoclonal antibodies generated 
against the 36 kDa glycosylase (Meyer-Siegler et al., 1992). 
Sequence analysis of the cDNA showed complete homology with 
glyceraldhyde-3-phosphate dehydrogenase. The transcription of 
this multifunctional gene was determined to be modulated by the 
proliferative state of the cell, and a correlation was found to 
exist between the transcription of the GAPDH/UDG gene and the 
level of uracil-DNA glycosylase activity (Meyer-Siegler et al., 
1992) . 
The developmental regulation of a 33 kDa uracil-DNA 
glycosylase was examined by in vitro biochemical assays in a rat 
model system (Weng and Sirover, 1993). In adult animals, liver, 
kidney and spleen displayed significant levels of activity while 
the brain, heart and lung had low activity. Glycosylase 
activity was minimal at early stages of life; however, maximal 
levels of activity were observed at 14-21 days after birth. 
These results led the authors to conclude that individual organs 
express. this enzyme in a distinct and specific pattern during 
development. 
15 
2. DNA glycosylase-AP lyases 
This type of DNA repair molecule releases modified 
nucleotides by a specific N-glycosylase activity and then 
hydrolyzes the phosphodiester bond 3' to the abasic sugar 
producing 5'-hydroxyl and 3'-phosphate termini. To date, all AP 
lyases (class I AP endonucleases - Figure 1) have been found to 
possess associated DNA glycosylase activities. 
Pyrimidine dimer-DNA glycosylase has been characterized in 
M. luteus and T4 phage-infected E. coli. The T4 phage gene 
(denV) has been cloned and found to encode a 16 kDa protein 
termed T4 endonuclease V (Radany et al., 1984; Valerie et al., 
1985) . Apparently, the two reactions are frequently uncoupled 
as the enzyme carries out the two cleavage reactions 
sequentially (Liuzzi et al., 1987). Mutants deficient for the 
T4 endonuclease V display hypersensitivity to UV, indicating 
that this enzyme plays a vital role in phage survival (Lindahl, 
1982). The M. luteus DNA-glycosylase is similar to T4 
endonuclease V in that its glycosylase and AP endonuclease 
activities are largely uncoupled. However, mutants deficient in 
the DNA-glycosylase activity have wild-type UV resistance that 
has been atributed to the organism's possession of a nucleotide-
excision repair system (Tao et al., 1987). Endonuclease III; 
is a class I AP endonuclease and minor contributor to the total 
AP endonuclease activity in E. coli. This enzyme has been found 
to posses a glycosylase activity which is specific for hydrated 
pyrimidines induced by UV radiation (Bailly and Verly, 1987). 
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Figure 2. Schematic of the base excision repair pathways. 
Upper pathway: class II AP endonuclease. Lower pathway: class I 
AP endonuclease. 
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In addition to its role as a ribosomal protein, the 
multifunctional Drosophila S3 protein was recently determined to 
function as a class I AP endonuclease (Wilson et al., 1994) . 
The cDNA of this gene was cloned utilizing the cDNA of the rat 
s3 homologue and was found to encode a small protein of 
approximately 27 kDa. Even more recent was the discovery that, 
like all other AP lyases, S3 has an associated glycosylase 
activity that is specific for the recognition and repair of 8-
oxoguanine residues, a major product of oxidative DNA damage 
(Kelley et al., 1995). 
3. AP endonucleases 
Apurinic and apyrimidinic sites are among the most common 
DNA lesions and can lead to polymerase halting, and, therefore, 
aberrant transcripts and even cell death (Zhou and Doetsch, 
1993). Consequentially, AP endonucleases have a critical role 
in the maintenance of DNA integrity and cell survival. The major 
cellular AP endonucleases belong to class II and can cleave the 
DNA backbone around an AP site 5' leaving a 3'-hydroxyl and a 
5' -phosphate termini (Doetsch and Cunningham, 1990) (Figure 2). 
The resulting 3' hydroxyl group is an excellent substrate for 
DNA polymerase I and does not require further processing (Warner 
et al., 1980). However, DNA polymerase I was found to be 
incapable of removing the abasic 5-deoxyribose molecule that is 
generated by this process (Mosbaugh and Linn, 1982). An enzyme, 
referred to as deoxyribose phosphatase (dRPase), that wa·s first 
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characterized in E. coli appears to function soley in the 
removal of 5' terminal deoxyriboses (Franklin and Lindahl, 
1988) . A functionally similar activity has been identified in 
human cells. 
As with most other DNA repair enzymes, AP endonucleases 
have been most extensively studied in E. coli. This organism 
contains two major class II AP endonucleases: exonuclease III 
and endonuclease IV. Exonuclease III is a multifunctional class 
II AP endonuclease, and the major AP endonuclease activity in E. 
coli comprising approximately 90% of the cellular AP 
endonuclease activity (Rogers and Weiss, 1980). It was first 
detected as a combined 3'-phosphatase-exonuclease separated from 
DNA polymerase I during purification (Richardson et al., 1964; 
Demple and Harrison, 1994). Exonuclease III is a single subunit 
enzyme of 28, 000 kDa that requires divalent metal (Mg2+) for it 
function (Sancar and Sancar, 1988). It has been shown to posses 
3'~5' exonuclease and 3' phosphatase activity on duplex DNA and 
RNase H activity on RNA-DNA hybrids (Richardson et al., 1964; 
Saporito and Cunningham., 1988; Weiss, 1981). 
AP endonuclease, it incises on the 5' side 
Being a class II 
of an AP site, 
leaving a 3' hydroxyl group and a 5' phosphate (Kow, 1989). 
Exonuclease III mutants (xth) are modestly sensitive to killing 
by methyl methane sulfonate (MMS) (Friedberg, 1985; Weiss and 
Grossman, 1987), and near UV (Sammartano et al., 1986), and are 
extremely sensitive to cell killing by H20 2 (Demple et al., 
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' 1983). These agents all create fragmented bases and/or AP sites 
(Sancar and Sancar, 1988). The hypersensitivity to H202 is due 
to the lack of removal of 3'-terminal deoxyribose fragments from 
radical-induced DNA strand breaks (Demple et al., 1986). 
Endonuclease IV is a class II AP endonuclease which 
represents 8-10% of total AP endonuclease activity (Ljungquist 
et al, 1976; Saporito and Cunningham, 1986). It is a monomeric 
protein of 33 kDa and is fully active in the presence of EDTA 
(San car and San car, 198 8) . Endonuclease IV mutants ( nfo) are 
sensitive to killing by the alkylating agents MMS and mitomycin 
c (Cunningham et al., 1986). Genetic studies have demonstrated 
that endonuclease IV functions in the repair of oxidative DNA 
damage in vivo. E. coli nfo mutants are hypersensitive to 
killing by the oxidative agents bleomycin and t-butyl 
hydroperoxide. Additionally, nfo mutations exacerbate the 
sensitivity of xth mutants to H20 2 (Cunningham et al., 1986). As 
will be discussed in detail in a later section, endonuclease IV 
was found to efficiently recognize 4'-oxidized AP sites 
generated by exposure of DNA to Fe (III)-bleomycin (Haring et 
al., 1994). 
The major AP endonuclease in S. cerevisiae is Apnl. This 
AP endonuclease is functionally similar to and structurally 
related to the E. coli endonuclease IV (Demple and Harrison, 
1994). Apnl is a class II AP endonuclease with 3' PGA 
diesterase and 3' phosphatase functions specific for duplex DNA 
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(Johnson and Demple, 198 8) , and its protein sequence of 3 67 
residues has a 41% amino acid identity to E. col.i AP 
endonuclease IV (Demple and Harrison, 1994). Additionally, like 
its E. coli homologue, Apnl functions to repair both oxidative-
and alkylation-induced DNA damage. Apnl mutants are 
hypersensitive to killing by H20 2 , t-butyl hydroperoxide, and 
alkylating agents (Popoff et al, 1990; Ramotar et al., 1991). 
The hypersensi ti vi ty was determined to be the result of un-
repaired oxidative strand breaks and apurinic sites in the yeast 
chromosomal DNA (Ramotar et al., 1991). 
Immunocytochemical analysis of Apnl in S. cerevisiae 
demonstrated that it is localized in the nucleus (Ramotar et 
al., 1993). The c-terminal segment of this protein, which is 
missing in its E. coli homologue, functions in the localization 
of Apnl to the nucleus. Truncation of this region was shown to 
restrict >90% of the protein in the cytoplasm without affecting 
the stability or enzymatic activity of the enzyme as 
demonstrated by in vitro assays (Ramotar et al., 1993). 
Two distinct AP endonucleases have been partially purified 
from Drosophila embryos (Spiering and Deutsch, 1981). The 
molecular weights of these two proteins, 66 and 63 kDa, is 
significantly higher than AP endonucleases isolated from other 
organisms. Biochemical assays for AP endonuclease activity has 
indicated that the 63 kDa protein is a class I AP lyase (these 
cleave 3' leaving a 3'-alpha, beta-unsaturated aldehyde) (Figure 
2) and that the 66 kDa protein is a class III AP endonuclease 
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(these cleave 3' to an AP site to yield an abasic sugar with a 
3'-phosphoryl group) (Spiering and Deutsch, 1986). This was the 
first, and only, report of a class III AP endonuclease. The 
antibody generated against the major human HeLa AP endonuclease 
was found to cross react with both Drosophila proteins 
indicating that they possess antigenic regions of similarity. 
Utilizing this antibody, studies have shown that the 66 kDa 
protein localizes to the nucleus while the 63 kDa protein 
translocates to the mitochondria (Dr. James Carney, personal 
communication). 
Drosophila possesses another AP endonuclease enzyme 
referred to as Rrpl that was originally purified based on its 
strand transferase activity (Lowenhaupt et al., 1989). The C-
terminal 250 residues of this protein have clear homology to the 
exonuclease III family, while the remaining N-terminal residues 
are not related to any known sequences (Sander et al., 1991a). 
Rrpl is a class II AP endonuclease with a 3' 5' exonuclease 
activity against undamaged, double-stranded DNA (Sander et al., 
199lb; Nugent et al., 1993). 
AP endonuclease have been cloned from a variety of 
mammalians including mouse, calf thymus, human placenta and 
human (Seki et al., 1991; Robson et al., 1991; Robson and 
Hickson, 1991; Seki et al, 1991). All are class II AP 
endonucleases, are similar in their molecular weights, around 
35. 5 kDa and are closely related to one another with 91..:.93% 
identity. This striking level of homology extends to the 
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prokaryotic homologues and suggests a significant conservation 
of function during evolution from a common ancestor (Figure 3). 
The mammalian AP endonucleases will be discussed in detail in 
the next section. 
o. Mammalian AP Endonucleases 
While biochemical evidence suggests that multiple human AP 
endonucleases exist, the cDNA for only one has been isolated 
(Demple et al., 1991). The purified protein of 37 kDa, termed 
APE, constitutes the main AP endonuclease activity of HeLa 
cells. This enzyme possesses all of the DNA repair functions of 
exonuclease III except for the 3' -exonuclease activity against 
undamaged DNA. Interestingly, the mouse homologue, APEX, was 
found to have exonuclease activity (Seki, 1991). While these 
homologues lack obvious amino acid changes, it has been 
suggested that the APE is lacking exonuclease activity due to 
sequence differences at an as yet undetermined conserved active 
site (Demple et al., 1991). As previously mentioned, APE is a 
class II hydrolytic AP endonuclease that incises 
thephosphodiester bond just 5' to the abasic site to generate a 
normal 3' -hydroxyl nucleotide terminus and a 5' -terminal 
deoxyribose-5-phosphate (Levin and Demple, 1990). Additionally, 
APE has 3' repair activity enabling it to remove fragments of 
deoxyribose from the 3' termini of DNA strand breaks produced by 
free-radical attack. However, this 3'-repair activity is weak 
equaling only about 1% of the AP-cleaving activity of 
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E. coli Exolll E coli Endo IV 
111111111111 
Human AP Endonuclease S. cerevisiae Apnl 
1111111111111 
28% Identity 41 % Identity 
Figure 3. Comparison of the families of class II AP 
endonucleases. 
exonuclease III in which 
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the 3' -repair and AP-cl.eaving 
activities are about equal (Demple et al., 1988; Levin et al., 
1988) . 
Complementation experiments indicate that hAPE can only 
partially replace its E. coli homologue, exonuclease III (Demple 
et al., 1991). While APE conferred significant cellular 
resistance to the alkylating agent methyl methanesulfonate, it 
provided only slight resistance to the oxidative agent H20 2 • As 
previously mentioned, exonuclease III-deficient E. coli are 
hypersensitive to the DNA damaging effects of hydrogen peroxide 
being unable to remove 3' -terminal deoxyribose fragments from 
free-radical induced DNA strand breaks (Demple et al., 1983; 
Demple et al., 1986). Therefore, considering the relatively 
weak 3'-repair activity of APE demonstrated in vitro, the human 
AP endonuclease appears to function poorly in vivo in the repair 
of 3' -terminal oxidative lesions and well in the repair of 
alkylation-induced AP sites (Demple et al., 1991). 
1. Multifunctional enzyme 
Recently, it was discovered that APE is a multifunctional 
enzyme. While studying the redox factor termed Ref-1 which is 
responsible for the oxidation-reduction regulated DNA binding 
activity of Fos and Jun, Curran and co-workers discovered that 
this factor is identical to the previously cloned APE 
(Xanthoudakis, et al., 1992a). The Ref-1/APE protein will for 
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the rest of the text be referred to as APE. c-fos and c-jun are 
members of a multigene family that is involved in signal 
transduction cascades associated with growth, differentiation, 
neuronal excitation, and cellular stress (Holbrook and Fornace, 
1991; Morgan and Curran, 1991). Being early response genes, the 
expression of these two genes is induced rapidly and transiently 
in many cell types by a variety of extracellular stimuli, and 
are thought to function in the coupling of short-term signals 
initiated at the cell surface to changes in cellular phenotype 
by regulating the expression of specific target genes (Morgan 
and Curran, 1991). Fos and Jun proteins mediate their function 
as either Fos-Jun heterodimers or Jun-Jun homodimers; Fos does 
not form homodimers. In a reduced redox state, the 
homodimer/heterodimer is able to bind to activator protein-1 
(AP-1) regulatory elements in the promoter region of target 
genes (Xanthoudakis et al., 1992b; Nakabeppu et al., 1988). The 
site of reduction-oxidation regulation of Jun DNA binding 
activity is a conserved cysteine residue (Abate et al., 1990). 
The redox activity of APE appears to be sensitive to the 
reduction-oxidation state of the protein; treatment of APE with 
thioredoxin was found to "activate" the redox activity of the 
protein (Xanthoudakis et al., 1992b) . This finding suggested· 
that a redox-sensitive group in APE is involved in the reductive 
activation of the FOS-JUN complex. To determine the region of 
the APE protein responsible for redox activity, Walker et al, 
1993, performed deletion and site-directed rnutagenesis analysis 
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of APE. All of the following results were derived from in vitro 
assays of recombinant APE protein. Truncation of the APE coding 
region indicated that the redox activity is mediated by 
sequences encoded within the 61 amino acid N-terminal domain. 
Additionally, it was found that this region is dispensable for 
the DNA repair functions of APE, but was necessary for 
reactivation of the DNA binding activity of oxidized Jun 
protein. As would be expected, this region is absent from 
exonuclease III which does not possess redox activity. By site-
directed mutagenesis, cysteine 65 was identified as the redox 
active site and has been proposed to form a disulfide bridge 
with cysteine 93; the redox state of the two cysteines would 
mediate APEs ability to perform redox regulation of the Jun 
protein (Walker et al., 1993). 
A more complete study of the amino acid regions involved 
in either DNA repair or redox regulation was performed by 
Xanthoudakis et al., 1994. N- and C-terminal truncated forms of 
histidine-APE fusion proteins were constructed and assayed for 
their redox and DNA repair activity. Gel retardation analysis 
utilizing purified FOS and JUN was used to determine the effect 
of the various deletions on redox activity. It .was determined 
that deletion of the N-terminal 62 amino acids results in a 92% 
loss in redox activity while truncation to N-terminal amino acid 
116 resulted in nearly a complete loss of function. However, 
the authors noted that the residual activity possessed by this 
deletion mutant may be attributed to carryover of DTT from a 
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preparative buffer, raising some concerti about the accuracy of 
their results. c-terminal truncations indicated that amino acids 
critical for the redox activity of APE are contained within the 
first 127 amino acids of the protein. For DNA repair activity, 
the conversion of acid-depurinated supercoiled plasmid DNA to 
open circle plasmid DNA by the recombinant protein was 
monitored. The N-terminal 162 amino acids of APE were found to 
be non-essential to it's AP endonuclease activity. Together, 
these results indicate that the redox and AP endonuclease 
activities of APE are encoded by distinct amino acid regions 
within the protein and that these activities are functionally 
separate. It must be noted again that all of the studies on the 
redox activities of APE have been performed in vitro by 
biochemical analysis. The presence/significance of this 
activity in vivo awaits further study. 
Recently, another activity was reported for APE. Okazaki, 
et al., 1994, determined that APE is involved in negative 
regulation of the parathyroid hormone (PTH) gene by 
extracellular calcium. This repression of PTH expression is 
mediated, in part, by high calcium levels that increases the 
interaction of the nCaRE (negative calcium-responsive DNA 
element) in the upstream promoter region of the PTH gene with 
its nuclear binding protein nCaREB (nCaRE binding protein). 
This in vitro study using recombinant APE protein and nuclear 
extracts indicated that APE binds to nCaREBs potentiating their 
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binding to ncaREs. Again, the significance of this activity in 
vivo has not been demonstrated. 
2. Gene regulation/expression 
DNA repair genes have generally been considered to be 
•"housekeeping" genes that are expressed at relatively the same 
basal level in all tissues. However, recent evidence has 
emerged which indicates that mammalian AP endonuclease gene 
expression is highly sensitive to various stimuli including the 
oxidative state of the cell along with differentiation and cell 
type. 
First, the functional deletion of human AP endonuclease 
expression was performed in a human cell line. Hela cells were 
transfected with a construct that expresses antisense APE RNA 
(Walker et al., 1994). While stable HeLa cell transfectants were 
normal in their growth rate, morphology and plating efficiency, 
they exhibited hypersensitivity to killing by a variety of 
alkylating and oxidative, agents but not to UV. This result was 
nearly identical to the study by Ono et al., 1994, which 
demonstrated increased sensitivity of rat glioma cells 
expressing antisense AP endonuclease RNA to DNA damaging agents. 
Of great interest in the HeLa cell study was the finding 
that the antisense transfectants were exceptionally sensitive to 
changes in oxygen tension. These cells displayed a high level 
of killing following exposure to both hypoxic (1% oxygen) and 
hyperoxic (100% oxygen) conditions. Examination of APE protein 
levels indicated that the expression of this protein was induced 
following hypoxic stress. This observation, along with previous 
studies that failed to show induction of APE protein expression 
by DNA damaging agents, led the authors to suggest that the 
induced level of APE expression was necessary to counteract 
cytotoxic agents generated during hypoxic growth conditions, but 
not by DNA damaging agents (Walker et al., 1994). 
Second, the expression of the mouse AP endonuclease (APEX) 
gene during mouse brain development was investigated by in situ 
hybridization and northern blot analysis by Ono and co-workers 
(Ono et al., 1995). Using in situ hybridization, APEX mRNA was 
found to be expressed at high levels in the telencephalon, 
brainstem, and cerebellum during the embryonic stages. During 
late embryonic and post-natal stages, APEX expression in the 
pyramidal and granular layers of the hippocampal formation, and 
in the cerebellum, was high. By northern analysis, the authors 
demonstrated that APEX mRNA levels decreased with development 
from embryonic to adult stages in the parietal cortex and 
cerebellum. The expression of c-fos and c-jun was also examined 
by northern analysis. c-f os mRNA expression in the parietal 
cortex and cerebellum was found to be undetectable at early 
developmental stages with a rapid rise of transcript levels at 
postnatal day 14. c-jun expression remained constant throughout 
development. From this study, · the authors concluded that the 
expression of APEX is developmentally regulated with the highest 
levels of expression being in proliferative zones of the brain. 
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This pattern of expression was suggested to indicate that APEX 
plays a role in the proliferation and/or differentiation of the 
brain during development, perhaps through the redox modification 
of AP-1 binding proteins (Ono et al., 1995). 
E. Clinical Relevance of Apurinic/Apyrim.idinic Sites 
A wide variety of chemotherapeutic agents target DNA 
causing a variety of damage including adduct formation, cross-
links, abasic sites, and single and double strand breaks. 
Bleomycin, a glycopeptide antibiotic, has been useful as a anti-
tumor agent in the treatment of a number of neoplasms. The 
cytotoxic effect of this agent has been determined to be through 
DNA damage (Harrison and Lazo, 1987). Bleomycin forms a ternary 
complex with molecular oxygen and Fe (II) (bleomycin-Fe (II)-02) 
that undergoes a reduction reaction forming "activated" 
bleomycin capable of reacting with DNA forming AP sites, and 
single and double strand breaks (Lazo and Sebti, 1991). It has 
been suggested that the reduction of the bleomycin complex is 
mediated by endogenous reducing agents such as glutathione, 
NADH, ascorbate, and various electron transport proteins (Levy 
et al., 1989). 
A side effect of the clinical use of bleomycin is 
pulmonary fibrosis which tends to manifest itself after repeated 
administrations (Lazo and Sebti, 1991). A number of studies have 
indicated that the toxic effect of bleomycin toward lung tissue 
may be through DNA damage (Harrison et al., 1989). Utilizing a 
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bleomycin sensitive strain of mice, Harrison et al., 1989, 
demonstrated that the persistence of DNA damage, rather than the 
initial level of strand scission, is responsible for the 
development of fibrotic lung disease. 
The study of DNA repair mechanisms involved in the repair 
of bleomycin-induced DNA damage has recently begun. Following 
repeated administrations of bleomycin to a sensitive mouse 
strain, one group discovered that, concomitant with initial 
inflammatory changes, there was a 2-fold increase in DNA 
polymerase ~ activity, a polymerase that is generally thought to 
be associated with base excision repair (Katsura et al., 1992). 
Haring et al., 1994, recently demonstrated the involvement 
of AP endonucleases in the repair of bleomycin-induced DNA 
damage. Two forms of AP sites can occur: regular sites which 
result from the hydrolysis of the N-glycosylic bond, and 
oxidized sites that are the result of free radical attack at 
positions c- 1', C-2' or C-4' of the sugar moiety (Figure 4). It 
has been demonstrated that "activated" bleomycin reacts with the 
C-4' position of the sugar residue generating a 4'-oxidized AP 
site along with strand breaks (Hecht, 1986) . In a study 
examining the recognition of oxidized AP sites by repair enzymes 
including endonuclease IV, exonuclease III, T4 endonuclease V, 
endonuclease III, and formamidopyrimidine-DNA glycosylase, it 
was found that 4'-oxidized AP sites are excellent substrates for 
endonuclease IV requiring 4-fold lower concentrations of the 
protein than for recognition of regular AP sites (Haring et al., 
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"Regular" AP Site 4' - Oxidized AP Site 
Figure 4. Coparison of the chemical structures of regular and 
oxidized sites of base loss (AP sites). 
1994). 
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Taken together, these results indicate that the base 
excision repair pathway, and AP endonuclease IV in particular, 
is involved in the repair of bleomycin induced 4' oxidized AP 
sites. These findings have significant implications for future 
studies on the prevention/treatment of bleomycin induced 
fibrotic lung disease. 
A. Anima1s 
CHAPTER III 
MATERIALS AND METHODS 
Wistar-Harlan rats were supplied by Harlan Laboratories 
(Indianapolis, IN). 
animals were used. 
For studies of adult animals, 400 gm male 
For developmental studies, pregnant dams 
(gestation day 0 = day of sperm positive) were used. Animals were 
killed by decapitation while anesthetized. Specimens were rapidly . 
dissected, immediately frozen in chilled 2-methylbutane (-20°C) and 
stored at -ao0c. 
B. Tissues 
Human biopsy (duodenum, colon, liver and skin) and autopsy 
(brain) tissue sections were obtained from Dr. John Duguid of the 
Roudebush VA medical hospital, Indianapolis, IN and from Dr. 
Cunningham of the Tissue Procurement Service, University of 
Indiana University hospital, Indianapolis, IN. 
c. Antibody 
The polyclonal 
endonuclease antibody 
rabbit anti-human apurinic/apyrimidinic 
(hAPE) was previously produced in this 
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laboratory. 
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The polyclonal rabbit anti-human MSH2 antibody was 
provided by Dr. Richard Fishel of the University of Vermont. 
D. Oligonucleotides 
Oligonucleotide primers were provided by the Wells Research 
Foundation Oligonucleotide Synthesis Facility. 
E. Screening cDNA and Genomic Libraries 
1. cDNA. A lambda gtll rat testis library was screened 
with radioactive labeled rat AP endonuclease cDNA by standard 
protocol (Maniatis, et al., 1982). Approximately 3.6 x 105 plaques 
were screened by plating 6 x 104 pfu/150 mm plate. The cell line 
XLl Blue-MRA was incubated with the library phage for 20 minutes 
at 37°c, mixed with prewarmed LB top agarose, and poured onto NZY 
agar plates. Plaques were nearly confluent and touching at the 
end of a six hour incubation at 37°c. The phage DNA was 
transferred to 0.45 micron nytran membrane (Ambion, Austin, TX) by 
placing the membrane over the top agarose for 1 minute. This was 
followed by denaturation for 2 minutes in 1.5 M NaCl~ 0.5 M NaOH 
and renaturation for 5 minutes in 1.5 M NaCl, 0.5 M Tris-HCl, pH 
8. 0. After a brief rinse in 2X SSC ( 3 M . NaCl I 0. 3 M sodium 
citrate, pH 7.0), the filters were dried on whatman paper and the 
DNA crosslinked to the filter in a Stratalinker. 
For hybridization, the filters were prehybridized for 1 hour 
at 42°c with 50% formamide, 5X Denhardt's solution (0.5% polyvinly 
pyrolidone, 0.5% BSA, 0.5% ficol), 1% sodium dodecyl sulfate 
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(SDS), 1 M NaCl, 10 mM NaP04·, pH 6.5, 0.1% pyrophosphate, and 250 
mg/ml salmon sperm DNA (heat denatured by boiling 10 minutes). 
PCR generated rAPEN cDNA was radiolabeled utilizing the Decaprirne 
kit from Ambion (Austin, TX) and added to the prehybridization 
solution and allowed to hybridize for 24 hours at 42°c. The 
filters were then washed in 0. 2X SSC for 2 0 minutes at 65 °c and 
wrapped in saran wrap. Autoradiographs were obtained by exposing 
film to the filters at -ao0c overnight. Plaques with positive 
signals were picked and placed in 500 µl of SM (100 mM NaCl; 8 mM 
MgSOcH20; 50 mM Tris-HCl, pH 7.5; 0.01% gelatin) with 10 µl of 
chloroform and stored at 4 °c. Three total rounds of plaque 
purification was completed until pure populations of a specific 
phage was isolated. 
2. Genomic. A rat genomic DNA library (Stratagene, La 
Jolla, CA) was screened with the rAPEN cDNA fragment using the 
same procedure described above. 
F. Purification of Lambda Phage DNA 
After positive phage clones were purified to homogeneity 
through successive screens, phage DNA was isolated to permit 
further analysis of the insert DNA. To isolate lambda phage DNA, 
the Quiagen lambda purification procedure (Chatsworth, CA) and 
Promega Wizard columns (Madison, WI) were utilized. An inoculum 
of 6 x 105 plaque-forming units (pfu) was mixed with the 
appropriate bacterial host strain (XLl Blue MRA cells for both the 
genomic and cDNA libraries) and al~owed to incubate at 37°C for 20 
37 
minutes . Approximately seven ml of prewarmed LB soft agarose 
(42°C) was added to the absorbed phage/bacteria mixture and spread 
onto a 150 mm NZY (86 mM NaCl, 8 mM MgS04•7H20, O. 5% yeast extract, 
1 % casein hydrolysate, 1. 5% Difeo agar, pH 7. 5) plate that was 
allowed to incubate at 37°c for· six hours. Ten ml of SM ( 100 mM 
NaCl, 8 mM MgS0,•7H20, 50 mM Tris-HCl pH 7. 5, 0 .1% gelatin) ·buffer 
was applied to the plate and an overni'ght incubation was performed 
at 4°c on a nutator. The buffer was removed from the plate, mixed 
with 100 µl chloroform, and the debris pelleted by centrifugation 
at 8,000 x g for 10 minutes. The supernatant was then incubated 
with 10 mg/ml RNAse and 4 mg/ml DNAse at 37°c for 30 minutes. Two 
ml of ice cold buffer L2 (30% polyethylene glycol 8000, 3 M NaCl) 
was added, gently mixed in, and the sample incubated on ice for 60 
minutes. The sample was centrifuged at 12,000 X g for 10 minutes, 
the supernatant discarded, and the pellet resuspended in 1 ml of 
buffer L3 (100 mM Tris-HCl, 100 mM NaCl, 25 mM EDTA, pH 7.5) using 
a pipetter. One ml of buffer L4 (4% sodium dodecylsulfate) was 
added· and mixed in followed by an incubation at 70°c for 10 
minutes. After a brief chilling on ice, 1 ml of buffer LS (2.55 M 
potassium acetate, pH 4. 8) was added and mixed and the sample 
centrifuged at 16,000 X g for 30 minutes, 4°C. The supernatant was 
collected avoiding the potassium dodecylsulfate layer. The lambda 
DNA was purified and concentrated using the Promega Wizard DNA 
Clean-up System. 
38 
G. Subcl.oning rAPEN cDNA I:nto pB1ueScript 
The cDNA insert was released from the lambda arms by 
digestion with the restriction enzyme EcoRI (5U/µg DNA) at 37°c for 
2 hours. The insert was isolated by electrophoresis of the 
digestion reaction on a 0.8% agarose gel followed by excision and 
elution from the agarose gel slice. The DNA fragment was purified 
by organic extraction and subsequently ligated into linearized 
pBSK KS(-) (Stratagene, La Jolla, CA) that had been digested with 
EcoRI and treated with calf intestinal alkaline phosphatase 
(CIAP) (BRL,Grand Island, NY). CIAP treatment was carried out by 
adding 2 µl of phosphatase enzyme (BRL; 24 U/ml) to the plasmid 
restriction digest and allowing the reaction to proceed for an 
additional hour at 37°c. The enzyme was killed by incubating the 
reaction at 65°c for 15 minutes and extracting with 
phenol/ chloroform twice. Digested/CIAP treated plasmid was gel 
purified and used in ligation reactions. For ligations, a 3: 1 
ratio of insert:vector was mixed with lX ligase buffer (lOX ligase 
buffer = 300 mM Tris-HCl, pH 7. 5; 100 MgC12 ; 100 mM OTT), ATP 
(final concentration of 1 mM), and 1 µl of T4 DNA ligase (Promega, 
Madison, WI; 1 Weiss U/ml) in a final volume of 20 µl. Ligations 
were performed at 14°c overnight. T4 DNA ligase was inactivated by 
heating the reaction to 65°c for 10 minutes. The tube was cooled 
on ice for 2 minutes and the entire reaction transformed into 
competent E. coli HB101 bacteria cells. 
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H. Sequencing 
One ml of an overnight culture containing the plasmid of 
interest was pelleted at 4, 000 rpm for 1 minute in a 1. 5 ml 
microfuge tube. The supernatant was ~spirated and the pellet 
vortexed for 10 seconds. 0.5 ml of STET buffer (8% sucrose, 50 mM 
Tris-HCl pH 8. O, 50 mM EDTA and 5% Triton X-100) and 10 µl of 
lysozyrne (10 mg/ml) was added. to the pellet, mixed and incubated 
at room temperature for 2 minutes. The tube was transferred to a 
heat block at 100°c for 1 minute followed by centrifugation for 5 
minutes at 14,000 rpm, 4°c. The .pellet was removed and 10 µl of 10 
N NaOH was added, the reaction mixed and incubated at 37°c for 10 
minutes. 0. 4 ml of ice-cold isopropanol was added and the tube 
placed at -20°c for 10 minutes. Following a 5 minute 
centrifugation, 
washed with 70% 
the supernatant was· 
ETOH. The pellet 
aspirated 
was then 
and the pellet 
dried at 65°c, 
resuspended in 16 µl of dH20 and placed on ice for the sequencing 
reaction. 
Sequencing was performed utilizing the Sequenase Version DNA · 
Sequencing Kit from USB. 7 µl of the plasmid sample was put into 
a clec;m 0.5 microfuge tube with 1 µl sequencing primer (2 pmol) 
and 2 µl 5X reaction buffer (200 rnM Tri~-HCl pH 7. 5, l.00 rnM MgC12 , 
250 rnM NaCl). The primer was annealed to the DNA by heating for 2 
minutes at 65°c and then cooling slowly to <35°c over a 30 minute 
period. After chilling the reaction on ice, it was mixed with 1 
µl 0. 1 M. DTT, 2 µl labeling mix ( 1. 5 µM ea.ch of dGTP, dCTP, and 
dTTP), 0.5 µl [35S]dATP and 2 µl Sequenase Polymerase (3.25. U) and 
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allowed to incubate at room temperature for 5 minutes. Next, 3.5 
µl of the labeling reaction was added to each termination mix 
(ddG, ddA, ddT, and ddC) and incubated an additional 5 minutes at 
37°c. The reactions were stopped by the addition of 4 µl of stop 
solution (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% 
xylene cyanol FF) and heated to 80°C for 2 minutes prior to loading 
onto a 6%. polyacrylamide gel. The samples were electrophoresed at 
60V for approximately 2.5 hours. The gel was dried under vacuum 
onto 3 mm Whatman chromatography paper (Whatman International 
Ltd., Maidstone, England) and exposed to film (Hyperfilm-MB, 
Amersham, Sweden) overnight. 
I. Tissue CUlture 
All cultures were maintained at 37°c in an atmosphere of 95% 
air, 5% C02. 
1 . Nb2 T-cells. Nb2 T-cells (clone llc), an immature 
rat T-cell line; were obtained from Dr. Li-Yuan Yu-Li of Baylor 
University, Houston, TX. The cells were cultured in 
maintenance medium consisting of Fisher's medium with 10% fetal 
bovine serum (FBS), 10% horse serum, 10-4 M 2-mercaptoethanol, .2 
mM glutamine and penicillin/s~reptomycin (50 U/ml and 50 µg/ml, 
respectively) . 
2. Al235 glioma cells. This is a human cell line that 
was obtained from Dr. Russ Pieper of Loyola University of 
Chicago, Maywood, IL. The cells were cultured in Dulbecco' s 
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modified essential medium (DMEM) supplemented with 10% FBS, 2mM 
glutamine and penicillin-streptomycin (50 U/ml and 50 µg/ml). 
3. KCNR neuroblastoma cells. This is a human cell that 
was provided by Dr. Kent Robertson of the University of Indiana 
school of Medicine, Indianapolis, IN. These cells were cultured 
in DMEM supplemented with 10% FBS, 2mM glutamine and 
penicillin/streptomycin (50 U/ml and 50 µg/ml). 
4. HL-60 and HL-60R myeloid leukemia ·cells. These lines 
were provided by Dr. Kent Robertson of the University of Indiana 
School of Medicine, Indianapolis, IN. The cells were cultured 
in RPM! supplemented with 5% FBS, 2mM glutamine and 
penicillin/streptomycin (50 U/ml and 50 µg/ml). For 
differentiation experiments, the cells were diluted to 2 x 105 
cells/ml in the above media that also contained 10-5 M retinoic 
acid dissolved in ethanol. Cell samples were collected every 48 
hours over a six day period for Western analysis. Controls 
samples contained an equal amount of ethanol (1/200 vol 
ethanol). 
5. 3T3 mouse fibroblast cells. This cell line was 
provided by Dr. David Williams of the University of Indiana 
School of Medicine, Indianapolis, IN. DMEM supplemented with 
10% FBS and penicillin/streptomycin (50 U/ml and 50 µg/ml) was 
utilized as the culture medium. 
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J. Tota1 RNA Extraction 
Total cellular RNA was isolated using a modification of a 
procedure previously described (Chomcyznski and Sacchi, 1987). 
Approximately 100 mg of liver tissue or 20 x 106 Nb2 cells was 
homogenized in 500 µl of guanidinium thiocyanate (GIT) buffer (4 M 
guanidine isothiocyanate, 25 mM sodium citrate, pH 7.0, 0.5% 
sarcosyl and 0.1 M 2-mercaptoethanol). The homogenate was 
extracted by the addition 50 µl 2 M sodium acetate, pH 4.0, 500 µl 
phenol, and 200 µl chloroform:isoamyl alcohol 49:1, incubation on 
ice for 15 minutes, and centrifugation at 10,000 x g for 15 
minutes at 4°c. The aqueous phase was transferred to a new tube· 
and the RNA precipitated by the addition of an equal volume of 
100% isopropanol followed by a 15 minute incubation on dry ice. 
The RNA was pelleted by centrifugation at 10,000 x g for 15 
minutes at 4°c. The isopropanol was aspirated and the resulting 
pellet resuspended in 50 µl of GIT (this step was omitted for 
tissue culture cells - the next step is the 70% ETOH wash). The 
pellet was fully dissolved by heating to 65°c and racking. The RNA 
was precipitated by the addition of 1/10 volume 3 M sodium 
acetate, pH 5.2 and an equal volume of 100% isopropanol followed 
by incubation on dry ice for 15 minutes and centrifugation. The 
pellet was then washed with 500 µl 70% ethanol, dried at 65°c for 2 
minutes and resuspended in 50 µl of diethylpyrocarbonate (DEPC, 
0.2%) treated water. Again, the pellet was dissolved by heating 
to 65°c. The final RNA sample was quantified for concentration and 
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purity using a Pharmacia GeneQuant (Piscataway, NJ) and stored at 
-ao0c until needed. 
K. Northern Aruil.ysis 
1. Purified total RNA. 10 µg of total RNA was 
precipitated with 0 .1 volume 3 M sodium acetate, pH 5. 2 and 2. 5 
volumes of 100% ethanol on dry ice for 15 min by centrifugation at 
10,000 x g at 4°c for 15 minutes, the supernatant aspirated and the 
nucleic acid washed with 70% ethanol. The resulting pellet was 
dried at 65°c until all residual ethanol was evaporated. The RNA 
was resuspended in 20 µl of RNA Loading Dye (50% forrnarnide; lX 
MOPS; 15% formaldehyde; 10% glycerol) and 1 µl of ethidium bromide 
(1 mg/ml) by heating at 65°c for 15 minutes with periodic mixing. 
After incubation at 65°c, the sample was spun down and fractionated 
on a formaldehyde-agarose gel (lX MOPS buffer (0.2 M MOPS, pH 7.0; 
50 mM sodium acetate, 10 mM EDTA), 1.2% agarose, and 5% 
formaldehyde) . The formaldehyde was added just prior to pouring 
the gel. RNA electrophoresis was performed at 80 V in 1 X MOPS 
buffer. At the completion of electrophoresis, the gel was 
photographed. The gel was prepared for transferring by soaking it 
for 2 X 30 minute periods in lOX SSC at room temperature with 
gentle shaking. During the gel washing procedure, 0. 22 micron 
nitrocellulose membrane (MSI, Westboro, Ma) was prewet in 
distilled water followed by a 15 minute soak in lOX SSC. The RNA 
was then transferred by capillary action overnight. RNA was 
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subsequently fixed to the membrane by crosslinking using a 
stratagene UV Stratalinker 1800 (La Jolla, CA). 
2. Premade Human Multiple Tissue Bl9t. Two premade 
Northern analysis blots were purchased from Clontech (Palo Alto, 
CA)· 
L. Reverse Transcription 
Three µg of total RNA were added to a reaction tube 
containing 1 X reverse transcription buffer (50 mM Tris-HCl (pH 
8.3) 75 mM KCl, 3 mM MgC12), 10 mM dithiotreitol, 2 mM each 
dNTPs, 100 pmol oligo-(dT) primers (Bethesda Research 
Laboratories, Gaithersburg, MD), and RNase-free deionized 
distilled water to a final volume of 19 µl. This mixture was 
heated for 10 min at 65°c and quenched on ice, and 200 U Moloney 
murine leukemia virus RNase reverse transcriptase 
(Superscript, Bethesda Research Laboratories)· in 1 µl are added 
for a total reaction volume of 20 µl. This mixture was 
incubated at room temperature· for 10 min and then at 42°C for 1 
hour. The reaction was terminated by heating .at 95°c for 5 min 
and quenching on . ice. RNase-H (2U) was then added to the 
reaction and incubated for 20 min at 37°c. 
M. Polymerase Chain Reaction 
Five µl of the reverse transcription reaction from each 
sample or 1 µg of lambda or genomic DNA was· d.iluted into a final 
volume of 100 µl in i X PCR buffer buffer (10 mM Tris-HCL, 1.5 mM 
MgCl , 50 mM KCl, pH 
(Promega, Madison, WI) 
8.3), 
and 
lU 
10 
Tfl thermostable 
pmol of each 
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polymerase 
5' and 3' 
oligonucleotide primers. The oligonucleotides for multiple 
tissue RT-PCR analysis were as follows: 5' oligonucleotide; 5'-
CTGGACTTACATGATGAATGCCCG-3' and 3' oligonucleotide; 5'-
GAAGAGATAACGCACTGGTCTCCT-3' . These oligonucleotides correspond 
to the region of the rat AP endonuclease gene at 748 bp 3' of 
the ATG and 47 bp 3' of the TGA, respectively. The 
oligonucleotide primers for genomic PCR analysis were: 
A: 5'-ATGCCGAAGCGGGGGAAGAG-3' 
B: 5'-CGAGCCAGAGACCAAGAAGAC-3' 
C: 5'-GAGCTGACCAGTACTGATGG-3' 
D: 5'-CATGAGCCACATTGAGATCC-3' 
E: 5'-GAAGAGATAACGCACTGGTCTCCT-3' 
The polymerase amplification was carried out using a MJ 
Research (Watertown, MA) programmable heating/cooling dry block 
for 25 cycles of amplification ( 94°c, 30 sec; 60°c, 1 min; 72°c, 
2 min), followed by 10 min at 72°c. For J?.T-PCR analysis, a 
reaction was performed as described above, but without the 
addition of reverse transcriptase as a test for the presence of 
contaminating genomic DNA in the RNA samples. The 
oligonucleotide primers spanned at least one intron for genomic 
contamination controls. 
Following amplification, 10 µl of each PCR product was 
electrophoresed on a 2% agarose gel containing 0.5 mg/ml 
ethidium bromide in Tris borate-EDTA buffer. After pho~ography 
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of the gels using UV light, they were prepared for transfer and 
blotted onto nitrocellulose. The nitrocellulose was 
prehybridized in 5 x Denhardt' s solution, 250 mg/ml denatured 
salmon sperm DNA, 1% (wt/vol.) sodium dodecyl sulfate (SOS), 
o.1% tetrasodium pyrophosphate, and 50% deionized formamide for 
12 h at 42°c. Hybridization was performed overnight under 
stringent conditions at 42°C in the same solution as that used 
for prehybridization, but included in the mixture was a [a-
32p] dCTP random primed AP endonuclease or his tone H3. 3 cDNA. The 
blots were washed under high stringency conditions in 1 x SSC 
and 0.5% SDS at room temperature for 15 min and then three times 
in O. 2 X ssc-0. 5% SDS at 65°c for 20 min/wash. The washed 
filters were blotted dry and exposed to x-ray film at -70°c with 
enhancing screens (Dupont/New England Nuclear, Boston, MA). 
N. 5'-End Mapping of rAPEN Transcript 
The 5' end of the rAPEN transcript was determined utilizing. 
the 5' /3' RACE Kit from Boehringer Mannheim (Indianapolis, IN). 
One µg of either the rat Nb2 T-cell line or rat testicular total 
RNA was mixed with a cDNA synthesis primer specific for the rAPEN 
transcript (5'-GAAGAGATAACGCACTGGTCTCCT-3'), deoxynucleotides, 5X 
cDNA synthesis buffer (250 mM Tris-HCL, 40 mM MgC12 , 150 mM KCl, 5 
mM DTT, pH 8.5), ru-fV reverse transcriptase (40 U) and the reaction 
brought up to 20 µl with dH20. This was incubated for 60 minutes 
at 55°c followed by a 10 minute incubation at 65°c. The cDNA was 
then purified using the Boehringer Mannheim High Pure PCR -Product 
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purification Kit and a homopolymeric tail appended using terminal 
transferase and dATP. 20 µl of the cDNA was mixed with lOX 
reaction buffer (100 mM Tris-HCl, 15 mM MgC12 , 500 mM Kcl, pH 8.3) 
and 2 mM dATP. The reaction mixture was incubated for 3 minutes 
at 94°c and chilled on ice. One µl of terminal transferase (10 U) 
was added and the reaction incubated for 10 minutes at 37°c 
followed by 10 minutes at 70°c and chilling on ice. PCR 
amplification of the dA-tailed cDNA was accomplished utilizing an 
oligo dT-anchor primer with 
nested rAPEN specific primer. 
with the oligo 
an attached known sequence and a 
The dA-tailed cDNA was mixed on ice 
dT-anchor primer ( 5' -
GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTTV-3'), the specific primer 
(5'-CATGAGCCACATTGAGATCC-3'), deoxynucleotides, Tfl DNA polymerase 
(1 U, Promega, Madison, WI), lOX reaction buffer (100 mM Tris-HCL, 
15 mM MgC12, 500 mM KCl, pH 8.3) and dH20 up to 50 µl. This 
reaction mixture was subjected to the following PCR cycling 
conditions: 72°C for 5 minutes, 94°c for 3 minutes, 
minute, 72°c for 3 minutes followed by 40 cycles of 
60°c for 1 
94°c for 30 
seconds, 60°c for 1 minute, and 72°c for 2 minutes with a final 
72°c incubation for 10 minutes. A second round of PCR 
amplification was performed to obtain a visible band by agarose 
gel electrophoresis. The conditions were same as above except the. 
5 µl of the first PCR reaction was used with a second nested rAPEN 
specific primer (5'-GGCCGAATTCGAGCTGACCAGTACTGATGG-3'). The 
fragment was then subcloned into pBSK ( Stratagene) utilizing the 
built in endonuclease restriction sites presertt in the oligo dT-
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anchor primer (Sall) and the second nested specific primer 
(EcoRI). 
o. Genomic DNA Isolation 
1. Nb2 DNA for Genomic PCR Analysis. Approximately 20 X 
106 Nb2 cells were lysed in a 50 ml conical tube with 8 mls of 
basic lysis solution (17 mM NaHC03 , 28 mM Na2C03 , 2mM EDTA pH 8. O, 
0.5% N-lauroyl sarcosine, 300 µg/ml Proteinase K) by pipetting the 
lysate up and down two to three times with a 5 ml pipette. The 
lysate was incubated at 37°c for three hours with periodic mixing. 
The lysate was mixed with 0.5 volume phenol/0.5 volume chlorbform 
by inverting the tube for 5-10 minutes until a phenol emulsion 
formed. The phases were separated by centrifugation at 2000 rpm 
for 5 minutes. The aqueous phase was removed to a new 50 ml 
conical tube and the organic extraction repeated once with a final 
chloroform extraction. The aqueous phase was transferred to a 25 
ml Erlenmeyer flask containing 1. 6 mls of 11 M ammonium acetate 
and mixed. 2. 5 volumes of 95% ethanol was added, the flask 
tumbled until the DNA precipitated into threads, and the DNA 
spooled out and washed in 70% ethanol. The DNA was partially 
dried and dissolved in 400 µl dH20 in a· 1. 5 ml microfuge tube by 
placing the tube at 37°c for 30 minutes with periodic tapping. 
Four µg of RNAse A was added to the DNA and the sample incubated 
at 37°c for 30 min. The organic extraction was repeated as 
described above. Th~ DNA was precipitated out by the addition of 
40 µl of 3 M sodium acetate and 1 ml of 95% ethanol. The DNA was 
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again spooled out, washed with 70% ethanol and dissolved in 400 µl 
dH20 overnight at 4 °c. 
2. · 3T3 Transfectants. Genomic DNA was isolated from 
transfected 3T3 fibroblasts utilizing the Puregene DNA Isolation 
Kit from. Gentra Systems, Inc. (Minneapolis, MN). Approximately 2 
million cells were lysed on their growing substrate (tissue 
culture plate) with 600 µl cell lysis solution and RNase A treated 
(12 µg) for 30 minutes at 37°C·. Protein in the sample was removed 
by adding 200 µl protein precipitation solution, vortexing 
vigorously for 20 seconds, and centrifugation at 12,000 x g for.3 
minutes forming a pellet. The supernatant was removed to a 
microfuge tube containing 600 µl 100% isopropanol and . mixed by 
inverting the tube. The DNA was pelleted out by centrifugation 
for 1 minute, washed with 70% ethanol and dried. DNA hydration 
solution was added to the pellet and placed at 65°c for 1 hour to 
rehydrate the DNA. 
P. Biochemica1 Ana1ysis of rAPEN Activity 
PM2 DNA was partially depurinated by heating 70°c at pH 5. 2 
for 15 minutes to produce roughly one AP site per DNA plasmid. 
Assay mixtures (50 µl) contained 25 mM Tris'.""HCl . (pH 7. 5), 10 mM 
MgC12 , 170 fmol of PM2 [3H] -DNA molecules (27 cpm/fmol molecules), 
and a sample of protein. Incubations were for 10 minutes at 37°c. 
The number of nicks introduced into closed circular PM2 D1iJA was 
determined by a nitrocellulose filter binding assay. 
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g. PUrification of GST-rAPEN Protein Frcm :tnc1usion Bodies 
To construct a Glutathione S-Transferase (GST) /rat ·AP 
endonuclease fusion construct, the cDNA was ligated downstream of 
the GST coding region in the plasmid pGEX-3X. cDNA with 
appropriate restriction sites at each end (5' -BamHI; 3' -EcoRI) 
compatable with pGEX-3X vector restriction sites was generated by 
polymerase chain reaction utilizing the rat AP endonuclease pBSK 
plasmid as a template and the following primers: 
5'- 5'-GGCCGGATCCATGCCGAAGCGGGGGAAGAG-3', 
3'- 5'-GGCCAATTCTACAGTGCTAGGTAAAGGGT-3'. 
The reaction mixture consisted of 1 µg of template, 10 pmols 
each primer, deoxynucleotides, Tfl DNA polymerase (1 U, Promega, 
Madison, WI), lX reaction buffer (10 mM Tris-HCL, 1.5 mM MgC12, 50 
mM KCl, pH 8.3) and dH20 up to 100 µl. The sample was subjected to 
the following PCR cycling conditions: 72°c for 5 minutes, 94°c for 
3 minutes, 60°c for 1 minute, 72°c for 3 minutes followed by 40 
cycles of 94°c for 30 seconds, 60°c for 1 minute, and 72°C for 2 
minutes with a final 72°c incubation for 10 minutes. The resulting 
PCR product was digested with BamHI and EcoRI (SU each/µg DNA) at 
37°c, gel purified, ligated into linearized pGEX-3X and transformed 
into competent cells. DH5a cells carrying the GST-rAPEN construct: 
were inoculated into 50 ml of LB plus 100 µg/ml ampicillin and 
incubated overnight at 37°c with shaking. The culture was diluted 
1:10 into prewarmed (37°C) LB plus AMP and allowed to incubate for 
1 hour at 37°c with shaking. Expression of the recombinant 
protein was induced by the addition of isopropyl-ft-D-thio-
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galactoside (IPTG) to a final concentration of 0.1 mM followed by 
an additional 3 hours of incubation. The cells were then pelleted 
(2, 000 rpm for 10 min.), washed once with PBS, repelleted · and 
resuspended in 2 ml of PBS. To lyse the cells, they were 
sonicated at 45 watts 3 X 5 minutes with 30 seconds between 
bursts. Triton X-100 was added to a final concentration of 0.1% 
and the cell lysate was centrifuged at 8, 500 x g for 10 minutes 
and the supernatant collected. The supernatant was then incubated 
in an elution column with 1 ml of glutathione-sepharose beads 
(Sigma, St. Louis, MO) overnight at 4°c on a nutator. The column 
was washed with 20 column volumes of PBS plus 0.1% Triton X-100. 
The protein was eluted with 50 mM Tris, pH 8.0, 10 mM glutathione 
and collected in 0.5 ml fractions. The fractions were analyzed by 
electrophoresis on a 12% SOS-polyacrylamide gel followed by 
coomassie blue staining. 
R. Gel purification of GST-rAPEN for Antibody Production 
To isolate the antigen for antibody production, the column 
purified GST-rAPEN protein samples were fractionated on a 12% 
SOS-polyacrylamide gel at 150 v. for 1. 5 hours. The gel was 
stained with comassie blue, destained, and the rAPEN band 
excised from the gel. The gel strip was then placed into 
dialysis tubing with 1 ml of lX sos electrophoresis buffer 
(0.125 M Tris-HCl; 0.96 M glycine; 0.5% SOS). The tubing was 
sealed and the antigen eluted in lX sos electrophoresis buff er 
at 150 V for 1 hour. The protein sample was dialyzed overnight 
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at 4°C against 1 L of dH20 and quantified using the Bio-Rad 
protein assay. A total of 1.8 mg of antigen was provided to 
HTI bioproducts (La Jolla, CA) for antibody production. 
s. Western B1ot Ana1ysis 
Ten µg of each sample was fractionated on a 12% SDS-
polyacrylamide gel at 150 V for 1 hour utilizing the BioRad 
Mini-Protean II system (BioRad, Hurcles, CA). The gel and 0.22 
micron nitrocellulose membrane (MSI, Westboro, MA) were soaked 
in transfer solution (25 mM Tris-HCl, 192 mM Glycine, 20% 
Methanol) for 30 minutes. The protein was transferred to the 
filter (90 V for 1 hour). Following transfer, the gels were 
soaked in 1 % blocking solution (Boehringer-Mannheim, 
Indianapolis, IN) for 1 hour and then incubated with primary 
antibody overnight at 4°c on a Robbins Scientific Western 
Incubation rotator (Sunnyvale, CA). Both rabbit anti-rAPEN and 
rabbit anti-hAPE antibodies were used at a dilution of 1:500 for 
Western blots. After four 10 minute washes with TBST (50 mM 
Tris-HCl, 
antibody 
Mannhiem) 
150 mM NaCl, 0.1% Tween 20, pH 7.5), secondary 
(peroxidase conjugated goat anti-rabbit, Boehringer-
was incubated with the blot for 30 minutes at room 
temperature. Cross-reacting proteins were detected using the 
Chemiluminescence Western Blotting Kit from Boehringer-Mannheim. 
53 
T. Purification of rAPEN Antibody 
Following the transfer of GST-rAPEN to nitrocellulose 
membrane as described in the Western blot analysis protocol, the 
membrane was briefly stained with Ponceau S ( 0. 2% Ponceau s, 3% 
trichloroacetic acid, 3% sulfosalicyclic acid) to visualize the 
recombinant protein. The strip of membrane containing the 
protei~ was cut out, destained with 20 mM Tris-HCL pH 7 .5, and 
blocked in blotto (50 mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20, 
pH 7. 5, 5% carnation powdered milk) for 1 hour. The membrane 
strip was then incubated with three ml of immune sera overnight at 
4°C. The next day, the strip was washed three times for 10 minutes 
each in TBST. To remove the bound anti-GST-rAPEN antibody, 250 
µl of ImmunoPure Gentle Ag/'Ab Elution Buffer (Pierce, Rockford, 
IL) was incubated with the strip in a humidified chamber for 20 
minutes on a rotator and collected. 
U. Imnunocytochemical Staining of Al235 Cells for the Human AP 
Endonuc1ease 
Al235 cells were grown on 60 mm plates to about 70% 
confluency. The cells were washed with PBS and fixed in a 2% 
paraformaldehyde/O .1% Triton X-100 solution for 10 minutes. : The 
cells were then rinsed with PBS and the plate wiped dry leaving a 
small circle of buffer and cells (approximately 1.5 cm in 
diameter). Blocking of non-specific antibody binding sites was 
accomplished by incubating the cells with 1.5% ovalbumin and 1.5% 
bovine serum albumin in PBS for 30 minutes at room temperature. 
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The block was wicked off and the cells incubated with the rabbit 
anti-hAPE antibody at a 1: 50 dilution in blocking solution for 3 
hours at room temperature in a humidified chamber. The cells were 
washed 3 X 5 minutes with PBS followed by incubation with the 
secondary antibody (biotinylated goat anti-rabbit antibody) for 1 
hour at room temperature. Following three more washes in PBS, the 
cells were incubated with Vectastain Elite .ABC reagent (Vector 
Labs, Burlingame, CA) for 30 minutes and washed once with PBS. 
The signal was developed by incubating the cells with the 
chromagen diaminobenzidine (Vector Labs) for approximately 3 
minutes followed by a brief rinsing in dH20. For counterstaining, 
the sections were incubated in 95% ETOH for 2 minutes, phyloxine 
eosin for 2 minutes, 95% ETOH for 2 minutes, rinsed with PBS and 
covers lipped utilizing Aqua-mount (Lerner Laboratories, 
Pittsburgh, PA) . 
V. Subce11u1ar Fractionation 
Approximately 20 x 106 tissue culture cells were dounce homogenized 
in 1 ml TES buffer (10 mM Tris-HCl, pH 7 .5, 1 mM EDTA, 250 mM 
sucrose) 15 times. PMSF was added to 0. 5 mM and aprotinin to 
0.25%. The homogenate was.centrifuges at 1000 x g for 10 minutes 
at 4°c to separate the crude nuclei from the post-nuclear 
supernatant (PNS). The PNS was centrifuged again to remove any· 
remaining nuclei. The protein fractions were analyzed by Western 
blot analysis as described in Methods .. 
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w. Inmunohistochemistry 
Human autopsy (brain) and biopsy (duodenum, liver, colon and 
skin) specimens were fixed in 4% paraforrnaldehyde, paraffin 
embedded and sectioned at 6 µm onto Superfrost/Plus slides 
'(Fisher, Itasca, IL). The sections were then baked at 60°c for 30 
minutes, deparaffinized in xylene, and hydrated through a series 
of graded alcohols ( 100%, 95%, 70%, 50%) to dH20. Non-specific 
antibody binding sites were blocked by incubation for 30 minutes 
with 10% goat serum in PBS (0.1 M, pH 7.4). Affinity purif'ied 
primary anti-hAPE antibody (rabbit anti-human polyclonal) was then 
incubated with the sections overnight at 4°c at a concentration of 
25 µg/ml in 10% goat serum/PBS. The sections were washed 3 x 5 
minutes in PBS followed by incubation with the secondary antibody 
(goat anti-rabbit IgG, Vector Labs, Burlingame, CA) at a 1: 100 
dilution in 10% goat serum for 1 hour. Following two five minute 
PBS washes, the sections were incubated with an aviden/biotin 
solution (ABC elite kit, Vector Labs) for 45 minutes. The signal 
was then developed by incubation with DAB (Vector Labs). After 
development of sufficient signal, the sections were washed briefly 
in dli20 and dehydrated through a graded alcohol series to xylene. 
The sections were coverslipped us~ng Permount (Fisher, Itasca, IL) 
and photographed. 
For histological staining, the coverslips were removed with 
xylene, the sections hydrated through a series of graded alcohols 
to dH20, and the sections stained with either hematoxylin/ eosin 
(HE) or toluidine blue. For HE., the sections were soaked in 
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carazzi' s hematoxylin for 7 .5 minutes, rinsed for 15 minutes in 
tap water arid placed in 95% ETOH for 2 minutes. The sections 
were incubated in phyloxine eosin for 2 minutes, 95% ETOH for 2 
minutes, 100% ETOH for 3 x 2 minutes, xylene for 3 x 2 minutes and 
coverslipped. For toluidine blue, the sections were incubated in 
a 25% solution of toluidine blue for 7 minutes followed by a brief 
rinse in dH20. The sections were dehydrated through .graded ethanol 
to xylene and coverslipped. 
x. Riboprobes for In Sit;u Hybridization 
cRNA probes for in situ hybridization were generated by 
utilizing polymerase chain reaction (PCR) generated primers. The 
primers were constructed so that they contained either the SP6 
(sense probe) or T7 (antisense probe) polymerase promoter 
recognition sequences. The primers used were as follows: 
rAPEN/sense: 
5'-AGGGATCCATTTAGGTGACACTATAGTAGTAAACACTGCTTCGGTG-3'; 
rAPEN/antisense: 
5'GGATCCTAATACGACT~ACTATAGGGAGGGTACTGATGGGTGAGTCCAGG-3' 
Colony PCR reactions were performed to generate template from 
DH5a cells tranformed with plasmids containing the rAPEN cDNA. 
The PCR reactions consisted of 1 X PCR buffer (100 mM Tris-HCL, 15 
mM MgCl , 500 mM KCl, pH 8.3), lU Tfl thermostable polymerase 
(Promega) and 10 pmol of each 5' and 3' oligonucleotide primers, 
and a stab of bacterial cells. The polymerase amplification was 
carried out using a MJ Research programmable heating/cooling dry 
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block for 25 cycles of amplification ( 94°c, 30 sec; 60°c, 1 min; 
12°c, 2 min), followed by 10 min at 72°C. 
The riboprobe synthesis were labeled with using the Ambion 
Maxiscript SP6/T7 Kit (Austin, TX). The reactions consisted of 1 
µg of PCR generated template, 2 µl 10 X buffer, 1 µl 200 mM OTT, 1 
µl Rnasin, 1 µl dATP, dCTP and dGTP, 100 µCi 35S-a.-thio dUTP (New 
England Nuclear, Boston, MA), and 1 U SP6 or T7 polymerase. This 
mixture was incubated at 37°c for 1.5 hours. Percent incorporation 
and probe counts were determined by using a scinitllation counter. 
Y. In Sit:a Hybridization 
AP endonuclease gene expression was studied by in situ 
hybridization using cRNA probes. 35S labeled anti-sense and sense 
probes were generated from the coding region of the rat AP 
endonuclease cDNA as described above. The tissue sections were 
incubated in 4% paraformaldehyde for 30 minutes, 0.2 N HCL for 30 
minutes, acetylated in 0.1 M triethanolamine containing 0.2% 
acetic anhydride for 10 minutes, and dehydrated through a graded 
alcohol ·series. The sections were then covered with 50 µl of 
hybridization buffer (50% deionized fort'namide, 10% dextran 
sulfate, 5X SSPE, 0.1% SDS, lX Denhardts, 2.5 mg/ml yeast tRNA, 10 
mg/ml herring sperm DNA, 0.1% NaPPi, 10 mM rATP, rUTP, rCTP and 
rGTP) containing 5 x· 106 cpm of probe per ml. Glass coverslips 
were applied, and· the sections were incubated overnight at 55°c. 
The next day, coverslips were removed and the sections were washed 
in 2X SSC for 30 minutes at 20°c, RNAse A. (5 mg/ml) for 60 minutes 
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at 37°c, 2X SSC for 30 minutes at 20°c, 0. lX SSC for 60 minutes at 
60°c and 0. lX ·SSC for 30 minutes at 2o0c. Sections were then 
dehydrated in alcohol containing 0.3 M ammonium acetate and dried. 
Film autoradiographs were generated by exposing slides to 
Kodak SBS film for 2 to 7 days. Emulsion autoradiographs were 
generated by dipping sections in prewarrned (42°C) Kodak NTB2 
emulsion and stored in the dark with Dryrite for approximately 2 
weeks. Sections were then developed by soaking in Kodak 19 
developer for 4 minutes,. rinsing quickl,y in dH20, soaking in Kodak 
fixer for 4 minutes and then stained with 0. 5% toluidine blue to 
facilitate identification of anatomical structures. 
Z. .Construction of AP Endonuc1ease Vectors 
A pUC18 plasmid containing the human SPC-A promoter region, 
the SV 4 0 small T intron and poly A (approx. 0. 4 kb) track was 
obtained from Dr. David Williams of the University of Indiana 
school of Medicine (Figure 5). The coding regions of the yeast AP 
endonuclease (ApnI), the human AP endonuclease (hAPE) and a 
truncated form · of the human AP endQnuclease (&lAPE) that is 
missing the first 450 bp but contains its normal nuclear 
localization signal KRGK (shown underlined in primer sequence) 
were amplified by polymerase chain reaction with primers that 
contained restriction sites allowing subcloning ~nto the pUC18 
plasmid multicloning site immediately downstream of the SPC-A 
promoter (Figure 5). The oligonucleotide primers were as follows: 
ApnI -
5': 5'-GGCCGTCGACATGCCTTCGACACCTAGCTTTG-3' 
3': 5'-GGCCGAATTCTTATTCTTTCTTAGTCTTCCTC-3' 
hAPE -
5': 5'-GGCCGTCGACATGCCGAAGCGTGGGAAAAAGGG-3' 
3': 5'-GGCCGAATTCTCACAGTGCTAGGTATAGGGTGA-3' 
Af1APE -
5': 5'-GGCCGTCGACATGAAGCGTGGGAAACATGATCAGGAAGGCCGG-3' 
3': 5'-GGCCGAATTCTCACAGTGCTAGGTATAGGGTGA-3' 
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The 100 µl PCR reaction consisted of lU Tfl (Promega, 
Madison, WI), reaction buffer (10 mM Tris-HCL, 1.5 mM MgCl, 50 mM 
KCl, pH 8.3), 10 mM dNTPs and 10 pmol each oligonucleotide primer. 
The resulting PCR products were purified with the Promega Wizard 
PCR Cleanup System and digested with 10 · U each Sal! and EcoRI at 
37°c for 2 hours. The restriction digests were then heat killed 
for 10 minutes at 72°C and purified again. The plasmid was 
digested with Sal! and EcoRI, purified, ligated to the inserts and 
transformed into competent DH5a cells as described in Method D .. 
The pUC18-SPC-A/Apnl construct was then digested with NdeI and 
SalI to remove the 3. 5 Kb SPC-A promoter region. The pUC18/Apnl 
containing ·fragment was gel purified as previously ·described. A 
plasmid containing the human phosphoglycerate kinase(PGK) promoter 
region (provided by Dr. ·David Williams) was digested with NdeI and 
SalI releasing the PGK promoter sequence that was then gel 
purified. The pUC18/Apnl fragment was ligated to the PGK promoter 
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and the resulting ligation mixture trans!ormed into competent DH5a. 
cells. The pUC18-PGK/Apnl construct was then digested with Sall 
and Hindlll to release the Apnl fragment. The pUC18-PGK fragment 
was gel purified. The pUC18-SPC-A/hAPE and pUC18-SPC-A/~PE 
constructs were digested with Sall and Hindlll to release the AP 
endonuclease coding regions. Gel purified hAPE and ~PE 
fragments were ligated to the pUC18-PGK fragment creating pUC18-
PGK/hAPE and pUC18-PGK/ ~PE. These constructs were transformed 
into competent DHSa cells. For transfection into the mouse 3T3 
fibroblast cell line, 
purified using the 
(Chatsworth, CA) . 
100 µg of each of the six constructs 
Quiagen tip 100 Plasmid Purification 
The plasmids were transfected into 
was 
Kit 
3T3 
fibroblasts utilizing DOT AP from Boehringer-Mannheim 
(Indianapolis, IN). Positive clones containing one of the six 
constructs were selected for using G418 (Gibco BRL, Grand Island, 
NY). After approximately ten days, G418 resistant colonies were 
visible and subcultured into separate wells of a 24 well plate. 
PCR analysis, using the primers made for plasmid construction, and 
Southern analysis were performed to detect cell lines carrying the 
transfected AP endonuclease sequences. One cell line for each of 
the six constructs was selected for further experimentation. 
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AA. Pro.tection of Mouse 3T3 Fibrobl.asts from Bl.eomycin Induced 
DNA Damage by Transfected DNA Repair Vectors 
Mouse 3T3 fibroblasts cell lines that had been transfected 
with and stably integrated by the AP endonuclease DNA repair 
constructs (SPC-Apnl, SPC-hAPE, SPC-~PE, PGK-Apnl, PGK-hAPE, 
PGK-~E) were grown to confluency on 60 mm tissue culture 
plates. The normal growth media was replaced with media 
containing either O, 10, 50 or 100 µg/ml bleomycin. The bleomycin 
was made up as a 4 mg/ml solution in 0.9% NaCl; the 0 µg/ml dose 
was 0.9% NaCl. After 1 hour of treatment, the media was removed, 
the cells washed twice with PBS and detached from the plates with 
0. 5 ml 0. 25% trypsin-EDTA. 1. 5 ml normal growth media was added 
to each plate and 5 X 104 cells were aliquoted to new 60 mm plates 
with 5 ml fresh growth media. A plate of each cell line at each 
bleomycin dose was collected and counted on a hemacytometer by 
trypan blue staining every 24 hours. 
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Figure 5. Schematic of AP endonuclease expression vectors 
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CHAPTER IV 
RESULTS 
A. C1oning and Sequencing of the rAPEN cDNA 
To investigate the developmental, tissue and sub-tissue 
specific 
enzyme, 
expression 
a cDNA 
of a crucial 
was cloned 
base 
that 
excision DNA repair 
encoded the rat 
apurinic/apyrimidinic (AP) endonuclease. The cDNA was initially 
isolated by reverse transcription-polymerase chain reaction (RT-
PCR) of total RNA isolated from the rat immature T cell line Nb2 
using oligonucleotides specific to the mouse AP endonuclease 
translation initiation and termination codon regions (Seki et 
al., 1991). Following the isolation, DNA sequencing of this 
clone was performed to verify that it was the rat AP 
endonuclease by nucleic acid homology to the mouse and human 
homologues (Demple et al., 1991; Seki et al., 1991). Due to the 
fact that the isolated cDNA clone may have posessed incorrect 
bases generated by PCR, the cDNA was used to screen a rat testis 
lambda gtl 1 cDNA library. Four positive phage clones were 
identified that were purified to homogeneity through a total of 
three successive screens. The cDNA inserts were' isolated from 
the phage arms by restriction digests with EcoRI and all were 
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sequenced and determined to be the rat homologue of the E. coli 
exonuclease III family of conserved AP endonucleases. The other 
three inserts were later determined to encode the rat AP 
endonuclease by PCR analysis. 
The original clone of 1198 bp was determined to contain an 
open reading frame that predicts a protein of 316 amino acids 
with a calculated molecular weight of -35. 4 kDa (Wilson et al., 
1994). The rat AP endonuclease has 85% DNA identity to the 
human and 93% identity to the mouse AP endonuclease homologues. 
Amino acid identity between the rat and mouse is 97% while the 
rat and human have 93% identity. Alignment of the amino acid 
sequence of the rat protein with human and mouse homologues 
demonstrated the conserved nature of this DNA repair enzyme 
family (Figure 6) (Wilson, T. et al., 1994). The highlighted 
cysteine 65 is conserved within all three proteins. 
B. Genomic Organization of the rAPEN Gene 
The human and - mouse gene structures have previously been 
published (Demple et al., 1991; Seki et al., 1991). To 
determine the re la ti ve genomic structure of the rat AP 
endonuclease gene, PCR 'anal;.ysis was performed on Sprague-Dawley 
DNA derived from liver, and on a rAPEN genomic lambda gtll clone 
(Figure 7). The results of the PCR reaction along with 
information gained from 5' Rapid Amplification of cDNA Ends 
(5'RACE) analysis and the cDNA clone, indicated that three exons 
contain the rAPEN coding region. The .structure of the rAPEN 
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Figure 6. Comparison of the amino acid 
endonuclease (rAPEN) with human (hAPE) 
homologues. Differences in amino acids are 
sequence. The conserved cysteine residue 
asterisk (Wilson, T. et al., 1994) 
sequence of rat AP 
and mouse (APEX) 
noted below the hAPE 
is indicated by an 
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Figure 7. Comparison of the genomic structure of the rAPEN gene 
with human and mouse homologues. The relative structure of the 
rAPEN was determined by PCR analysis as described 'in the 
Materials and Methods section. 
67 
gene is different from its human and mouse counterparts which 
encode the AP endonuclease within four codons. The second to 
last intron present in the human, 567 base pairs, and mouse, 463 
base pairs, genes is apparently absent from the rat AP 
endonuclease gene. 
c. 5'RACE of rAPEN Nb2 and Testicular mRNA 
cDNAs isolated from· cDNA libraries are often missing 5' -
flanking sequences, especially those that are generated using 
oligo dT primers. Therefore, 5'-RACE was performed on total RNA 
isolated from both the rat Nb2 T-cell line and 60-90 day old 
Sprague-Dawley testis to determine the 5'-end of the rAPEN 
transcript (Figure 8) . In both Nb2 and testis, the 
transcriptional start site was found to be approximately 109 
bases upstream of the translational start site. This is 26 
bases longer than was isolated from the library cDNA. As is 
obvious from the alignment of the 5' RACE product and the cDNA 
clone, sequence differences exist between the two rAPEN 
transcripts. While the variance may be due to differences that 
may occur in isolated rat breeding colonies, the possibility 
also exists that alternative upstream codons are utilized. 
D. Tissue Specific Expression of rAPEN mRNA 
To examine the tissue specific expression of rAPEN mRNA, 
multiple tissue comparative RT-PCR analysis was performed on 
total RNA isolated from 60 - 90 day old male rats (Figure· 9). 
5' RACE: 
cDNA: 
5' RACE: 
cDNA: 
5' RACE: 
cDNA: 
TTTCTACATACATACTCCATTCTTTGTGC--AGTGAGGGGCTCCCTGCCTCATT 
CGGAGTGAGGGGCTCCCTGCCTCGTT 
GGGAGG-----CAGCGTAGTAAACACTGCTTCGGTGCTCCAGACGCCTAAGGG 
GGGAGGTCAGGCAGCGTAGTAAACACTGCTTCGGTGCTCCAGACGCCTAAGGG 
CTTTCGTTACAGCGATG 
CTTTCGTTACAGCGATG 
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Figure 8. Alignment of the 5' -end of rAPEN cDNAs isol_ated by 
5'RACE and cDNA library screening. 
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rAPEN-
-- 231 hp 
B3.3 --
-- 213 hp 
Figure 9. Comparative RT-PCR of the steady-state mRNA levels in 
various rat tissues for the AP endonuclease gene. Total RNA was 
isolated and subjected to RT-PCR (25 cycles) using the histone 
H3.3 transcript as an internal control. for reverse transcription 
and amplification variance. The blot was transferred and probed 
with the rat cDNA for the AP endonuclease gene or a histone H3.3 
specific DNA fragment. 
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After normalizing rAPEN mRNA levels to histone H3.3 levels, it 
was determined that the rat AP endonuclease gene was expressed 
in all tissues examined. Northern blot analysis of various 
tissues revealed a transcript of approximately 1. 5 Kb with the 
highest signal present in testis and spleen (Figure 10). A 
similar pattern of expression has also been observed in human 
tissues as well (Figure 11) • However, this type of analysis 
does not reveal the true nature of AP endonuclease tissue 
specific expression and can lead to erroneous and misleading 
conclusions concerning the lack of differential expression of AP 
endonuclease mRNA in various tissues, in particular, and DNA 
repair, in general. 
E. In situ Hybridization Ana1ysis of rAPEN Gene Expression 
During Feta1 Deve1opment 
To ascertain whether the AP endonuclease gene was 
differentially expressed in any tissues during fetal rat 
development, in situ hybridization was performed on a 
developmental series of tissue sections, days 8, 14 and 17. At 
all ages examined, which spanned periods of organogenesis and 
neurogenesis, a high level of AP endonuclease mRNA expression 
was present in all somatic sites examined (Figure 12) . At 
gestation day (GD) 8, the fetus was examined within the uterus. 
A moderate hybridization signal was present over the entire 
embryo. At GD 14, the somatic pattern of labeling was 
widespread with a strong hybridization .signal present over all 
I 
:I 
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Figure 10. Multiple tissue · Northern blot analysis rAPEN mRNA 
e xpression . In three separate studies , total RNA isolated from 
v arious tissues of a 60-90 day old male Sprague-Dawley rat was 
e lectrophoresed on a 1. 25 % agarose gel , blotted to Nytran and 
probed with labeled rAPEN cDNA. Total RNA loading was judged to 
be relatively similar by examination of RNA levels by ethidium 
b romide staining (data not shown). 
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Figure 11. Multiple tissue Northern blot . analysis of hAPE rnRNA 
expression. Prernade rnul tiple tissue Northern blots, A and B, 
were obtained from Clontech that contained 2 µg poly A+ rnRNA per . 
lane. The blots were probed with the hAPE cDNA. 
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T 
PL 
s 
Figure 12. In situ hybridization of rAPEN mRNA during fetal 
development. The developmental expression pattern of AP 
endonuclease mRNA was examined at gestation days (GD) 8, 14, and 
17, from left to right, respectively. PL= placenta, S = spinal 
cord, H heart, LV = liver, T telencephalon, M 
mesencephalon, SM submandibular gland, TH thymus, - I 
intestine, K = kidney, L lung, BF brown fat. In all 
experiments, the sense RNA probe gave essentially no background. 
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organs that could be identified. While AP endonuclease mRNA was 
expressed at high levels in all structures examined, when 
relative hybridization signals were compared among different 
organs, AP endonuclease mRNA levels were the greatest in the 
liver, thymus and brain. At GD 17, the pattern was relatively 
unchanged to that observed at GD 14. 
F. Distribution and Differentia1 Expression of rAPEN mRNA in 
Adu1t Rat Brain 
Following up on the striking observation that rAPEN mRNA 
was highly expressed in specific regions of the developing rat 
brain, the regional expression of the AP endonuclease gene in 
adult brain was examined by in situ hybridization. This 
investigation revealed a widespread but heterogeneous pattern of 
distribution of rAPEN transcript. The rat AP endonuclease mRNA 
was expressed at moderate levels throughout the entire brain; 
however, it was expressed at very high levels in several 
distinct brain regions (Figures 13 and 14). rAPEN mRNA was the 
most prevalent in the hippocampus, suprachiasmatic nuclei (SCN), 
the site of the . circadian clock, and in the supraoptic nuclei 
(SON) and paraventricular nuclei (PVN), nuclei that regulate 
water level balance (Rivkees ·and Kelley, 1995). High levels of 
AP endonuclease expression were also found in .the pyrif orrn 
cortex (Figures 13 and 14), a region involved in olfactory 
signaling. Emulsion autoradiographs revealed that labeling in 
the cortex was heaviest over the pyramidal cells in layers III 
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Figure 13. In situ hybridization of AP endonuclease mRNA on 
adult, male rat saggital and coronal brain tissue sections. -AP 
endonuclease mRNA expression was examined using . saggital or 
coronal tissue sections at 100 um intervals spanning the entire 
brains of rats (n = 3 or more per orientation, although only one 
section per orientation is shown). Areas of higher AP 
endonuclease expression are; pyriform cortex (PC), hippocampus 
(H), cerebellum (CB), suprachiasmatic nuclei (SC) and supraoptic 
nuclei (SO) . Only the antisense probes are shown as the sense 
probes showed no background level of hybridization (see Figure 
15). T =thalamus, LM =lateral mammilary body, SN= . substantia 
nigra, PN= pontine nucleus. 
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Figure 14. Emulsions of the in situ pattern of AP endonuclease 
gene expression in adult male rat brains. Labeling was seen in 
several cortical layers in emulsion autoradiographs (A & B). 
Detailed analysis of the hippocampus is presented in C & D and 
in the cerebellum i-n E & F. Py = pyramidal cells or neurons, H 
= dentate hilus, CAl, CA2 and CA3 are regions of Ammon's horn, 
Pc or P = Purkinje cells, M = molecular layer, G or GR = granule 
layer , W = white matter. 
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and V. Lower levels of labeling were also · seen over cells in 
the other cortex layers (Figure 14). 
rAPEN mRNA expression was also detected at high levels in 
the hippocampal formation (Figures 13 and 14), a region involved 
in short term memory and motor neuron control. Emulsion 
autoradiographs revealed heavy labeling over granule cells in 
the dentate gyrus (Figure 14). In the dentate hilus, labeling 
was present 
(Figure 14). 
over· pyramidal ·neurons and not over interneurons 
In Ammon' s horn, heavy labeling was seen over 
pyramidal cells in the CAl, CA2 and CA3 regions. Specific, but 
low level labeling of interneurons could be detected in the 
stratum oriens, lacunosum-moleculare, and radiatum (Figure 14). 
In the cerebellum (Figures 13 and 14), Purkinje cells were 
the most heavily labeled cell type. In the molecular layer, 
there was low level labeling of cells, while in the granule 
layer, there was a moderate hybridization signal. The deep 
cerebellar nuclei also expressed high levels of AP endonuclease 
mRNA (Figure 14). In the basal ganglia, which contains 
different sub-populations of neurons, moderate labeling of all 
neurons was observed. 
G. Differential EXJ?ression of rAPEN mRNA in Adult Rat Testis 
With the finding of sub-tissue differential .AP 
endonuclease gene expression in specific brain cells, another 
tissue of predicted importance for DNA BER activity, the testis, 
was examined. Because of the differential exp·ression of AP 
endonuclease gene 
expression pattern 
vigorous cellular 
expression in 
of these genes 
differentiation 
78 
post-mitotic tissue, the 
in a tissue undergoing 
and cell-cycling was of 
interest. The testis are ideal for these in vivo studies since 
they fit this criteria and understanding DNA repair gene 
expression in developing germ cells has important ramifications 
for the production of mature sperm with intact and faithful 
genomic copies. Emulsion autoradiographs generated from in situ 
hybridization studies revealed that AP endonuclease mRNA 
expression varied with the stage of spermatogenesis (Figure 15). 
AP endonuclease mRNA was present at modest levels over 
spermatogonia and spermatocytes. However, the highest level of 
AP endonuclease mRNA expression was detected over round 
spermatids which are postmeiotic cells. Sense probes on these, 
and the previously shown developmental and brain sections, 
revealed no non-specific hybridization (Figure 15). 
H. overexpression of Recombinant GST-rAPEN Fusion Protein 
To obtain rAPEN protein for DNA repair biochemical 
activity assays as well as for antibody production, recombinant 
glutathione S-transferase (GST) -rAPEN protein was overproduced 
and affinity and gel purified. The rAPEN coding region. was 
amplified from.the cloned cDNA by PCR using oligonucleotides 
specific to the nucleotide sequences of the translational start 
and stop codon regions. The resulting fragment of expected size 
was subcloned into the expression vector pGEX-3X for 
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Figure 15. In situ hybridization for AP endonuclease mRNA on 
adult male testis. In three separate studies using testes from 
different animals, prominent . hybridization signals were seen for 
AP end.onuclease mRNA in developing round spermatids. SG 
spermatogonia, SC = spermatocytes, RS = round spermatids, ES = 
elongating spermatids. The top panel is a dark field exposure 
of emulsions of a cross section through . the testis tubules. The 
middle panel represents a magnified view of the intense pattern 
· of AP endonuclease expression in the round spermatids. The 
bottom panel is an exposure of a sense RNA probe showing the 
lack of any background signal. 
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overproduction of a GST rAPEN fusion protein. The resulting 
recombinant protein was purified by affinity chromatography and 
was determined to have a molecular weight of approximately 63 kD 
(GST-26 kD, rAPEN-37 kD) s expected (Figure 16). The affinity 
purified GST-rAPEN was then further purified to apparent 
homogeneity by SDS-PAGE purification. 
I . Biochemical. Activity of rAPEN 
The data presented in Table 2 demonstrate the specific 
activity for the rat AP endonuclease on AP containing DNA, 
verifying the AP endonuclease specific activity of the rat AP 
endonuclease. In direct comparisons of recombinant rat and 
human AP endonuclease activity, both had similar activity on AP 
DNA and no activity on non-AP containing DNA. These proteins 
were assayed as glutathione S-Transferase fusion proteins with 
the GST portion neither hindering the activity nor adding 
significantly to the specific activity of the rat and human AP 
endonucleases. 
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Figure 16. . SDS-PAGE analysis of affinity purified -recombinant 
GST-rAPEN protein. Supernatant containing GST-rAPEN fusion 
protein derived from whole cell -sonicate was affinity purified 
on a glutathion-sepharose column. Fractions of 0. 5 ml were 
eluted from the column and 10 µl of each was electrophoresed on 
a 12% polyacrylamide-SDS gel followed · by coomassie blue 
staining. The arrow indicates the fusion protein of the 
predicted molecular weight. 
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TABLE 1 
Rat AP endonuclease Repair Activity 
Reactions (50 µl) contained 25 mM Tris-HCl, pH 7.5, 10 mM MgC12 , 
170 fmol of PM2 [ 3H]-DNA in which the depurinated DNA substrate 
contained roughly one AP site per DNA circle and 50 ng of 
protein. 
Addition Nicks introduced/ 
DNA molecule 
AP NT 
GST-rAP endonuclease 0.43 0.01 
GST-hAP endonuclease 0.61 < 0. 01 
GST 0.11 0.09 
Table I. GST-rAP endonuclease is the rat AP endonuclease (Huq 
et al., 1995) and GST-hAP endonuclease is the human AP 
endonuclease (Demple et al., 1991) produced as glutathi~me-S­
transferase fusion proteins in E. coli. 
83 
J. Subcellular Expression of the rAPEN Protein 
To examine the sub-cellular expression of the rat AP 
endonuclease protein in the rat Nb2 immature T-cell line, and 
the rat Hl9-7 hippocampal cell line, polyclonal rabbit anti-GST-
rAPEN antibody was reacted with 10 µg each total cell extract, 
crude nuclei, and cytoplasm (post-nuclear supernatant), by 
Western analysis. The antibody specifically cross-reacted with 
a 37 kD protein in all lanes indicating that the rAPEN protein 
is located in both the nucleus and cytoplasm of both cell lines 
(Figure 17). While the bands appeared to be of relatively the 
same intensity, one must keep in mind that the amount of protein 
in nuclei only represent a small fraction of the total protein 
of the entire cell. Therefore, this procedure "enriches" the 
concentration of rAPEN in the nuclear lane as compared to the 
cytoplasmic. Additionally, the method of purification of the 
crude nuclei may have resulted in the presence of contaminating 
structures such as Golgi apparatus in this fraction that might 
have produced an incorrect result for the crude nuclei. 
K. Specificity of the hAPE Antibody 
The specificity of the polyclonal rabbit anti-hAPE 
antibody (Duguid et al., submitted) was determined using total 
cellular extracts from the hliman cell lines A1235 (glioma), KCNR 
(neuroblastoma), and human liver (Figure 18). By Western blot 
analysis, the antibody cross-reacts with a single band at 37 
kDa, the molecular weight of human APE. 
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Figure 17. Western analysis of Nb2 and H19-7 subcellular 
fractions for rAPEN protein expression. Approximately 20 X 106 
cells were dounce homogenized and separated into crude nuclei 
and cytoplasmic fractions by centrifugation. Ten µg of each of 
these fractions along with total cell extract was fractionated 
on a 12% polyacrylamide-SDS gel and transferred_ to 
nitrocellulose. The blots were incubated with anti-rAPEN 
antibody and the signal developed by chemiluminescence. 
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Figure · 18. Demonstration of hAPE antibody specificity by 
Western analysis. Total cell extracts (20 ug) from the human 
glioma cell line A1235, neural blastorna KCNR and human J.iver 
were run on a 12% SDS-polyacrylarnide gel, blotted and reacted 
with affinity purified antibody to the human AP endonuclease 
enzyme. Only a _single protein band of 37 kDa was observed. 
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L. Subcellular Loca1ization of hAPE in Al235 Glioma Cells 
To determine whether our antibody performs similarly to 
the antibodies utilized in previous reports (Demple, et al., 
1991; Xanthoudakis, et al., 1992), and to investigate the 
location of the protein in a brain cell line, the sub-cellular , 
of location of hAPE protein in the human glioma cell line A1235 
was determined by . immunocytochemistry. As in the previous 
studies, the hAPE protein appeared to be primarily located in 
the nuclei of the cells with no readily visible signal present 
in the cytoplasm (Figure 19A). No signal was detected when pre-
immune rabbit immunoglobulin was utilized as the primary 
antibody (Figure 19B). 
M. Subcellular Fractionation of hAPE Protein 
To determine the subcellular localization of hAPE protein 
in the human neuroblastoma cell line A1235, Western analysis was 
performed on extracts of crude nuclei and post-nuclear 
supernatant, (Figure 20). 
kDa protein band (hAPE) 
The antibody reacted with a single 37 
that was present in all fractions; 
however, the total cell extract lane was overloaded. 
As stated for the subcellular fractionation of rAPEN, the 
amount of protein in nuclei only represents a small fraction of 
the total protein of the entire cell. Therefore, this procedure 
"enriches" the concentration of hAPE in the nuclear lane as 
compared to the cytoplasmic. 
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Figure 19. Subcellular localization of hAPE in A1235 glioma 
cells by immunocytochemistry. A12-35 cells were incubated with 
anti-hAPE antibody and cross-reactivity detected using an 
aviden/biotin system. The cells were stained with phyloxine-
eosin. 
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Figure 20. Western analysis of KCNR subcellular fractions for 
hAPE protein expression. Approximately 20 X 106 cells were 
dounce homogenized and separated into crude nuclei and 
cytoplasmic fractions by centrifugation . Ten µg of each of 
these fractions along with total cell extract was fractionated 
on a 12% polyacrylamide-SDS gel and transferred to 
nitrocellulose. The blots were incubated with anti-hAPE 
antibody and the signal developed by chemiluminescence. 
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N. Expression of hAPE in Duodenum, Hepatocytes and Epidermis 
To characterize the expression of hAPE in vivo, 
immunohistochemistry of human biopsy specimens including 
duodenum, hepatocytes, and epidermis, was performed. The 
duodenum demonstrated a strong anti-hAPE antibody reaction with 
enterocyte nuclei of the proximal villus and the crypts of 
Lieberkuhn (Figure 21A}. The nuclei of the distal villus showed 
little reaction. Hematoxylin and eosin staining of an adjacent 
section showed the continuity in appearance of the enterocytes 
across the region of discontinuity of hAPE staining (Figure 
21B) . 
The distribution of hAPE staining in hepatocytes was 
dramatically different from that observed in the duodenum and 
A1235 cells. There was uniform staining of the cytoplasm and 
reticular staining of the nuclei that surrounds the nucleoli 
with clear staining of the nuclear rim (Figure 22A and 22B). 
Anti-hAPE staining of the epidermis was uniform and strong 
in the nuclei from the dermis up to the stratum granulosum. The 
staining in the granulosum was somewhat less than that of the 
lower strata of the epidermis, and there was little or no 
staining of the strata lucidum and corneum; staining in the 
cytoplasm was present but considerably less strong (Figure 23A). 
An adjacent section showed that the hAPE staining was not 
restricted to the chromatin stained with hematoxylin, but w~s 
highly expressed throughout the entire nucleus (Figure 23B). 
I • ' I • 
.. 
' 
B 
90 
Figure 21. Imrnunohis-tochemistry analysis of hAPE expression in 
duodenum. A. hAPE imrnunohistochemistry demonstrates a strong 
reaction with enterocyte nuclei of the proximal villus and the 
crypts of Lieberkuhn (CL). The nuclei of the distal villus are 
not stained (see arrow) . B. Hematoxylin and eosin staining of 
an adj~cent section shows the enterocytes on the villus and in 
the crypts of Lieberkuhn (CL). Little difference is seen · with 
the histochemical staining of the proximal and distal villus, 
c ompared to the imrnunohistochemical reaction with hAPE antibody. 
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Figure 22. Immunohistochemistry analysis of hAPE protein 
expression in hepatocytes. A. hAPE antibody stains the 
cytoplasm and nucleus of hepatocytes; the nuclear rim is 
stained · (vertical arrows ) and the nucleoli are spared 
(horizontal arrow) . B. Hematoxylin and eosin staining of an 
adjacent section. · 
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Figure 23. Immunohistoc:ochemistry analysis of hAPE protein 
expression in the epidermijll:llis. A. hAPE immunohistochemistry of 
the epidermis shows strong 1a.g nuclear staining from the dermis up 
to the stratum granulosum. There the staining in the granulosum 
is somewhat less than the . e lower strata of the epidermis, and 
there is little staining of!O f the strata lucidum and corneum. 
B. Hematoxylin and eosin s staining of an adjacent section show 
that the strong, homogeneo .~ ous hAPE staining of individual nuclei 
in the epidermis does not ~ correspond to the hematoxylin staining 
of chromatin in these nuclei.lei. 
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0 . Di-tribution of hAPE Expression in Brain 
The distribution of hAPE in the hippocampus is presented 
in Figure 24A, which shows antibody reactivity in neurons in the 
dentate gyrus and regions CA3 and CA4. No reaction was observed 
when pre-immune .rabbit immunoglobulin was used in place of the 
primary antibody (Figure 248). Further, this reaction was 
inhibited by preincubating the primary antibody with recombinant 
antigen (data not shown). At higher magnification, hAPE in the 
dentate gyrus (Figure 24C) and CA4 (Figure 240) was seen to be 
primariiY cytoplasmic in both sites, as observed in hepatocytes. 
hAPE immunoreactivity in the cerebellum is shown in Figure 
25A. The nuclei of some granule neurons were stained evenly and 
darkly, but others showed no reaction. In the Purkinje cells, 
the cy~oplasm was stained uniformly while the nucleus was 
stained in a reticular manner around a circular structure in the 
center of the nucleus, and there was subtle staining of the 
nuclear rim. Subsequent staining of the same field with 
hematoxylin revealed that the circular structure was the 
nucleolus and the reticular hAPE staining material was chromatin 
(Figure 258). 
[1APE staining of the hypoglossal nucleus of the brainstem, 
where motor neurons that control tongue movement reside, 
demonstrated reactivity in discrete regions of the cytoplasm of 
these J'{lotor neurons (Figure 26A). Subsequent staining with 
cresyl violet and photography of the same field demonstrated 
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Figure 24. Immunohistochemistry analysis of hAPE protein 
expression in the hippocampus. A. Low magnification view shows 
staining of both the dentate gyrus and pyramidal cells of 
regions CA3 and CA4. B. Tissue stained with rabbit preimmune 
serum at a protein concentration three fold higher than the 
concentration used with hAPE indicates little, if any, 
background staining. C. and D. High magnification views of the 
dentate gyrus (C) and region CA4 (D). 
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Figure 25. Inununohistochemistry analysis of hAPE protein 
expression in the cerebellum. A. hAPE immunohistochemistry 
demonstrates the strong staining of some granule neuron nuclei 
(horizontal arrows) . The immunohistochemical reaction of the 
Purkinje cell nucleus suggests that the reaction spares the 
nucleolus and stains chromatin. This is confirmed by sequential 
staining of the same slide with hematoxylin, shown in B. Arrows 
indicate the Purkinje cell nuclear chromatin in panel A. 
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Figure 26. APE immunohistochemistry of hypoglossal nuclei motor 
neurons. A. The APE immunohistochemistry of hypoglossal motor 
neurons suggested that the reaction was with Nissl substance 
(aggregates of ribosomes that are prominent in motor neurons and 
are stained with cresyl violet). B. The coverslip was removed 
from the slide and the section was stained with cresyl violet. 
The same field that was photographed in panel A is shown in 
panel B, demonstrating that the APE reaction product does stain 
Nissl substance. Arrows indicate Nissl substance in panel A. 
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Figure 27. hAPE protein expression during the apoptotic 
process. The myeloid leukemia cell line HL-60 was induced to 
undergo apoptosis by treatment with retinoic acid. Cell samples 
were collected every two days over a six day course. Ten ug of 
total cell extract of each sample was fractionated on a 12% 
polyacrylamide gel and transferred to nitrocellulose. The blots 
were incubated with anti-hAPE antibody and cross-reactions 
detected by chemiluminescense. 
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Q. Specificity of the hMSB2 Antibody 
The specificity of the polyclonal rabbit anti-hMSH2 (human 
mutS homologue) antibody provided by Dr. Richard Fishel of the 
University of Vermont was determined using total cellular 
extracts from the human cell lines Al235 (glioma) and HL-60 
(myeloma). By Western blot analysis, the antibody cross-reacts 
with a single band at 105 kDa, the molecular weight of human 
MSH2 (Figure 28). 
R. Expression of hMSB2 in Duodenum and Col.on 
To compare the localization of a DNA repair enzyme 
involved in a different repair pathway to that found for the 
human AP endonuclease, irmnunohistochemistry for the hMSH2 
protein was performed. Irmnunohistochemistry of the duodenum 
demonstrated a strong reaction in the nucleus of striated-
bordered cells in the crypts of Lieberkuhn (DiFore, 1974), 
although the hMSH2 antibody did not recognize every cell (Figure 
2 9) . There was some staining of nuclei in enterocytes of the 
proximal villus and very sporadic, if any, staining of the 
distal villus nuclei occurred. Toluidine blue staining of the 
same section showed the continuity in appearance of the 
enterocytes across the region of discontinuity of MSH2 staining 
(Figure 29). Incubation with preirmnune IgG as a primary 
antibody in place of the anti-hMSH2 antibody resulted in no 
staining of any cells (Figure 29). 
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Figure 28. Specificity of the hMSH2 antibody. Total cell 
extracts (20 µg) from the human cell lines A1235 (astrocytoma), 
HL-60 (cell line of leukemic myeloid precursor cells), and human 
liver cell extract were run on a 7% SDS-polyacrylamide gel, 
blotted and reacted with purified antibody to the human MSH2 
mismatch DNA repair enzyme. Only a single protein band of 105 
kDa was observed. 
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Figure 29. Immunohistochemistry analysis of hMSH2 expression in 
the duodenum.. A-C: hMSH2 immunohistochemistry demonstrated a 
strong reacti~rn with cells in the crypts of Lieberkuhn (CL). 
The nuclei · of the proximal or distal villus were not stained. 
Arrow points to crypt that is also shown at higher magnification 
in B. B: Higher magnification view o{ crypts of Lieberkuhn 
shown in A (arrow). C: Crypts shown following counterstaining 
with toluidine blue. The antibody staining of hMSH2 appears as 
dark brown. Notice that not every cell in the. crypts stained 
and that there was little staining of cells outside of .the 
crypts. D: Preimmune IgG reaction with duodeum. No staining was 
observed for the preimmune IgG in the tissues. 
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Figure 30. Irrununohistochemistry analysis of hMSH2 in the colon. 
A-C. hMSH2 antibody staining of colon tissue. A: hMSH2 antibody 
staining without counterstain. B: Higher magnification view of 
crypts shown in A {arrow) and counterstained with toluidine 
blue. Notice the heavier staining in the lower third section of 
the crypt. Blue staining cells in the interior of the crypts 
are the goblet cells that did not react with hMSH2 antibody. C: 
In contrast to the results seen in duodenum, fibroblase cells 
(arrow) surrounding the crypts also react with hMSH2 antibody, 
although, as in the crypt cells, not every cell stained. D: 
Colon reacted with preirrunune IgG showed no background antibody 
reaction. 
In the large intestine (colon), 
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the hMSH2 antibody 
predominantly stained the lower one to two thirds of the crypts 
and little, or no staining was observed in the outer third 
(Figure 30). Again, preinunune IgG did not result in non-
specific background antibody staining of any cells (Figure 30). 
Goblet cells did not stain with the hMSH2 antibody (Figure 30), 
as observed in the duodenum (Figure 29). 
S. B1eomycin Treatment of 3T3 Ce11s Transfected with the 
ApnI, hAPE and Ah.APE Mammalian Expression Vectors 
Bleomycin is a chemotherapeutic agent utilized for the 
treatment of a variety of carcinomas. The use of this drug has 
been limited due to the development of lung fibrosis in a 
relatively large percentage of patients. This side effect is 
thought to result from the DNA damaging effects of bleomycin in 
lung cells. Therefore, the development of a protective therapy 
for lung cells again.st the DNA damaging effects of bleomycin is 
desirable. An initial study of bleomycin treated mouse 3T3 
fibroblasts indicated that a 50 µg/ml dose of bleomycin resulted 
in a 25% reduction in total cell number over a 72 hour period as 
compared to untreated 3T3 cells. To see if the yeast Apnl AP 
endonuclease or the human AP endonuclease could provide 
protection against the oxidative DNA damage induced by the 
radiomimetic agent bleomycin, 3T3 cells were transfected with 
one of six constructs: PGK-Apnl 1 PGK-hAl?.~.1 PGK-Llli.APE, SPC-A-
ApnI, SPC-A-hAPE, or SPC-A-MlAPE. 
expressed human phosphoglycerate 
should direct the expression of 
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The PGK is the ubiquitously 
kinase promoter region that 
the AP endonuclease coding 
region in the 3T3 cells. The SPC-A is a lung specific 
surfactant gene promoter sequence that should not direct 
transcription of the AP endonuclease coding region in 3T3 cells. 
The ~PGK-hAPE and SPC-A-MlAPE constructs contain truncated hAPE 
coding regions that will produce DNA repair proficient proteins 
missing the N-terminal region purported to be involved in redox 
activities (Xanthoudakis et al., 1994). 
The transfected 3T3 cells were treated with either O, 10, 
50 or 100 µg/ml bleomycin for 1 hour, subcultured at 5 X 104 
cells per plate and a sample counted every 24 hours. The 
preliminary results of the bleomycin treatment after 72 hours 
are depicted in Figure 31. PGK-ApnI transfected 3T3 cells 
exhibited an approximately 3-fold higher survival rate than the 
3T3 cells alone. Additionally, PGK-hAPE displayed an 
approximately 2-fold increase in survival while the PGK-MlAPE 
construct did not confer any protection 
induced cell killing. The control vector, 
provide any protection as expected. 
against bleomycin 
SPC-ApnI, did not 
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Figure 31. Enhanced survival of rnurine 3T3 fibroblasts 
transfected with AP endonuclease coding regions after treatment 
with bleornycin. 3T3 cells alone and transfected with either the 
PGK-ApnI, PGK-hAPE, PGK-~hAPE or SPC-ApnI expression vector were 
treated with 100 g/rnl bleomycih for 1 hour and allowed to grow 
for an additional 72 hours. Total cell numbers were counted and 
the results presented as percentage survival relative to 
control. 
CHAPTER V 
DISCUSSION 
Living organisms are continuosly exposed to DNA damaging 
agents, both exogenous and endogenous, that can form a wide 
array of DNA alterations and modifications. On a day to day 
basis, however, the formation of apurinic/apyrimidinic (AP) 
sites is one of the most common types of DNA damage, resulting 
from both spontaneous loss of bases and from oxidative free 
radicals that are byproducts of an oxidative respiratory system. 
Modified bases can lead to aberrant base pairing while AP sites 
in DNA have been shown to hinder transcription and, if not 
:repaired, lead to altered transcripts and transcript levels 
(Zhou and Doetsch, 1993). The accumulation of DNA lesions has 
been postulated to be a significant and central cause of aging 
and neuronal degeneration (Warner and Price, 1989; Rao and Loeb, 
1992; Boerrigter and Vijg, 1993; Weirich-Schwaiger et al., 
1994). Therefore, the role of the base excision repair pathway 
in the repair of damaged bases and AP sites in DNA is crucial. 
While the E. coli homologue has been extensively 
characterized, very little is currently known about the 
regulation and expression of the mammalian AP endonuclease. The 
predominant theory proclaims that mammalian DNA repair genes in 
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general are "housekeeping" in nature and are not interesting 
from a differential expression/gene regulation point of view. 
Indeed, initial studies ·of this dissertation examining rAPEN 
mRNA expression by reverse transcription-polymerase chain 
reaction and nornthern analysis demonstrated relatively similar 
levels of transcript expression between the different tissues. 
However, as was demonstrated, this type of analysis does not 
reveal the true nature of AP endonuclease cell and tissue 
specific expression and can lead to erroneous and misleading 
conclusions concerning the lack of differential expression of AP 
endonuclease mRNA in various tissues, in particular, and DNA 
repair, in general. The purpose of this dissertation was to 
examine the developmental, tissue and sub-tissue specific 
expression of the mammalian class II AP endonuclease. 
To begin to determine the expression of rAPEN in vivo, in 
situ hybridization was performed on adult rat brain sections and 
a series of fetal rat sections that spanned the developmental 
stages. Examination of the distribution of AP endonuclease mRNA 
in adult rat brain revealed a widespread, but heterogeneous 
pattern of distribution. Of these regions, most of which were 
either the more metabolically active brain cells or sites of 
excitatory amino acid (EAA) action, several sites were of 
particular interest. In agreement with previous observations, 
AP endonuclease mRNA expression was highly expressed in the 
suprachiasmatic nuclei, which is the site of a circadian 
pacemaker.(Moore et al., 1989; Rivkees and Kelley, 1994). ·AP 
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endonuclease mRNA levels were also very high in the supraoptic 
and paraventricular nuclei, which are involved in the regulation 
of water balance (Shen, 1992). Previous studies have shown that 
AP endonuclease mRNA in these structures appears to be 
constitutively expressed at a higher level than found in the 
majority of other cells and is not regulated by circadian, 
photic, or osmotic stimulation at the mRNA level (Rivkees and 
Kelley, 1994). Since these structures are important sites of c-
Fos/Jun action (Aronin et al., 1990; Kornhauser et al., 1990; 
Rea et al.-, 1993), high level AP endonuclease expression in 
these structures may be related to the c-Fos/Jun redox state 
regulation. However, AP endonuclease mRNA levels were found to 
remain unchanged with external perturbations known to induce c-
Fos/Jun in these cells (Rivkees and Kelley, 1994). The high 
levels of AP endonuclease mRNA, and presumably AP endonuclease 
enzyme, may be present in these structures solely for DNA repair 
functions. The possibility remains that the AP endonuclease 
expression/activity is regulated at the translational and/or 
post-translational levels. 
High levels of· AP endonuclease mRNA expression were also 
detected in the hippocampal formation. This result was in 
agreement with the findings of Ono et al, 1995, on the 
expression of AP endonuclease in mouse brain. The hippocampus is 
a metabolically active tissue that is a major site of excitatory 
amino acid (EAA) action (Coltman and Monaghan, 1986). EAA are 
capable of inducing cell damage, which triggers oxidative-damage 
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of DNA (Coltman and Monaghan, 1986). Because AP endonuclease is 
involved in oxidative DNA damage repair, 
endonuclease expression in these cells 
mechanism evolved for this type 
Furthermore, the results showed that 
the high level of AP 
may be a protective 
of cellular damage. 
high levels of AP 
endonuclease mRNA were present in granule cells of the dentate 
gyrus and pyramidal cells of Ammon's horn, which are also major 
sites of EAA action (Coltman and Monaghan, 1986). Thus, high 
level AP endonuclease gene expression may also protect neurons 
in these regions. Within this hypothesis, the observation that 
there was low level AP endonuclease mRNA expression in the 
dentate hilus is intriguing due to the fact that the hilus is a 
major site of hippocampal degeneration in seizure disorders and 
EAA toxicity models (Swanson, 1995). Studies to determine if 
low levels of AP endonuclease in this region contribute to the 
vulnerability of cells in the hilus to exocitotoxic damage may 
provide useful information. 
In the cerebellum, high levels of AP endonuclease mRNA 
were observed in Purkinje cells. These cells are very 
metabolically active and are innervated by excitatory 
projections (Coltman and Monaghan, 1986). The deep cerebellar 
nuclei, which also receive excitatory projections (Coltman and 
Monaghan, 1986), also expressed high levels of AP endonuclease 
mRNA supporting the concept that the AP endonuclease is 
expressed at sites of EAA action or in metabolically active 
brain cells. Pyramidal cells of the cerebral cortex that 
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receive excitatory projections also expressed relatively high 
levels of AP endonuclease mRNA. Furthermore, DNA polymerase p, 
the enzyme responsible· for BER DNA 
localized in the adult rat brain to 
synthesis, 
the cortex, 
has been 
cerebellum 
(particularly the Purkinje cells) and hippocampus, similar 
regions as demonstrated here for the AP endonuclease (Zucconi et 
al., 1992). 
During rat fetal development, AP endonuclease gene 
expression was very prominent. At the ages examined, which 
spanned periods of organogenesis and neurogenesis, high level AP 
endonuclease mRNA expression was present in all somatic sites 
examined. This pattern of expression during development may 
help protect the embryo and fetus against potential DNA 
replication errors that may occur during active periods of 
mitosis. ·Since pre- and post-natal ·AP endonuclease mRNA 
expression was not compared, it is not known if expression of 
this gene is greater during organogenesis than at later stages. 
At the gestational times studied, AP endonuclease mRNA levels 
were exceptionally high. in the liver and thymus. During this 
period, the liver has a predominant role as an hematopoietic 
organ, as opposed to in adults when the liver is more involved 
in detoxification. The expression of the DNA BER pathway is· 
currently being investigated in developing and purified 
populations of human hematopoietic cells in this laboratory. 
Individuals afflicted with a DNA-repai~ disorder display a wide 
range of clinical symptoms, including skeletal abnormalities and 
altered growth. 
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Further detailed analyses of the differential 
expression of the BER pathway during development may help . to 
shed light on these observed clinical phenotypes. 
When AP endonuclease mRNA expression was examined in the 
testis, rAPEN mRNA levels was found to vary with the stage of 
spermatogenesis. rAPEN mRNA expression was present at modest 
levels over spermatogonia and spermatocytes. However, the 
highest levels of :r::APEN mRNA were detected over round 
spermatids. These are post-meiotic cells that mature into 
spermatozoa via a process that involves nuclear condensation 
(Clermont, 1972). Thus, although rAPEN mRNA was expressed 
throughout germ cell development, its expression was greatest 
after completion of meiosis during spermatozoa maturation. High 
level AP endonuclease expression at this stage would thus favor 
correction of DNA errors before mature sperm are formed. 
The differential expression of the rat AP endonuclease 
gene in specific regions of rat brain, testis and particular 
tissues during development is in marked contrast to the 
expression of the NER gene ERCC3, which has been shown to be 
evenly and ubiquitously expressed in mouse brain during 
development (Hubank and Mayne, 1994) . Therefore, the 
differential ·expression of the rAPEN transcript in the various . 
tissue and subtissue regions is unique and not simply a -general 
DNA repair gene mode of expression. 
This type of analysis allows us to begin to understand the 
regulation and functional relationship of this gene product to 
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the various cell types while, at the.same time, raising many new 
questions. For example, why is the level of expression of the 
AP endonuclease gene so strikingly high in the suprachiasmatic 
nuclei (SCN), paraventricular nuclei (PVN) and supraoptic nuclei 
(SON)? Why is AP endonuclease also highly expressed in pyriform 
cortex, hippocampus and cerebellum? What is its function during 
fetal development and what controls the level of expression? Why 
do round spermatids in developing germ cells express such a high 
level of the AP endonuclease mRNA compared to the other germ 
cell stages? While explanations have been suggested, many more 
studies, both in vivo and biochemical analyses, must be 
performed to arrive at answers to these questions. 
Studies examining the correlation between rAPEN mRNA and 
protein expression in the various tissues would have been 
beneficial; however, this was not possible due to the 
ineffectiveness of the anti-rAPEN antibody in 
immunohistochemistry experiments. 
currently being produced. 
A new polyclonal antibody is 
The striking results of the rAPEN in 
studies led to the analysis of human 
situ hybridization 
tissue samples. 
Fortunately, the anti-human AP endonuclease antibody previously 
generated in this laboratory was very effective for this method. 
allowing analysis of hAPE protein expression in various human 
tissues (Duguid et al., 1995). 
To date, 
distribution 
no studies have been performed on the sub-tissue 
of hAPE in any human tissues. The· only 
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immunohistochemical studies previously performed on human cells 
have used transformed cell lines. One such study demonstrated 
speckled staining of the nuclei of osteosarcoma cells in culture 
with little cytoplasmic staining (Demple, et al., 1991), while 
the other showed nuclear rim staining in another cell line 
following the overexpression of a vector containing the hAPE 
cDNA (Xanthoudakis et al., 1992a). Similar to these previous 
reports, the immunocytochemical staining of A1235 glioma cells 
presented in this dissertation demonstrated intense nuclear 
staining with little apparent cytoplasmic staining (Figure 19). 
Western analysis of sub-cellularly fractionated HL-60 cells 
demonstrated the presence of hAPE in all fractions examined, 
including crude nuclei, postnuclear supernatant, cytoplasm, 
ribosomes, and mitochondria (Figure 20). This result indicates 
that the hAPE protein is present in all the cell areas examined; 
however, due to the method of purification, the possibility 
exists that the mitochondrial fraction was contaminated with 
other cellular structures such as Golgi apparatus. The 
difference between the immunocytochemical and Western analyses 
results may be explaned by the fact that immunocytochemistry is 
a strictly qualitative form of analysis: hAPE may have been 
present in the cytoplasm of the examined cells but not at levels 
detectable by .this metpod. As will be apparent by the 
discussion the follows, what has been observed in these in vitro 
studies is not necessarily the case in vivo. 
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Immunohistochemistry of hAPE in vivo using biopsy 
specimens demonstrated a diverse and drastically different 
picture of hAPE protein expression in the various organs and 
cell types. Two tissues have been identified in which the hAPE 
expression was markedly affected by the normal maturation of 
their cells. In the duodenum, enterocytes are generated in the 
crypts of Lieberkuhn and, over a period of approximately two to 
four days, they migrate out of the crypts and up the villi 
toward the tip where they are sloughed into the intestinal lumen 
(Wheater et al., 1982). It was found that the enterocyte nuclei 
abruptly stopped staining with hAPE antibody well before they 
had reached the villus tip and at a time when they were 
morphologically normal. A similar pattern has been noted for 
alkaline phosphatase expression (Wheater et al., 1982) , which 
suggests that there is a marked change in gene expression· that 
occurs in the maturation of enterocytes which is not reflected 
in their morphology. This pattern of staining was in contrast 
to what has been observed with the MGMT DNA repair protein. 
Immunohistochemical ·analysis of MGMT in rat duodenum showed a 
homogeneous staining pattern of enterocyte nuclei from the 
crypts all the way to the tips of the villi (Zaidi et al. , 
1993). In addition, the antibody to the human MSH2 mismatch DNA 
repair protein demonstrates staining predominantly in the nuclei 
of the crypts with little staining in the cells of the villi 
(Wilson et al., 1995), while MLHl, another human mismatch DNA 
repair protein is expressed in all enterocytes of the villi 
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similar to MGMT expression (unpublished data). Therefore, the 
various DNA repair proteins of several· different pathways: 
direct reversal (MGMT), mismatch (MSH2, MLHl), and BER (hAPE) 
all show a different and distinct pattern of expression in the 
duodenum. The relationship of this differing pattern of 
expression for DNA repair proteins in one tissue, such as 
duodenum, is intriguing and requires further detailed 
investigation. 
Epidermal cells are generated in the basal layer of the 
epidermis and over approximately 30 days migrate to the 
superficial layers where they keratinize and are sloughed 
(Wheater et al., 1982}. There was a clear morphological change 
that corresponded with the loss of hAPE antibody staining. As 
the cells keratinize and die, they appear to stop expressing 
hAPE. The staining of epidermal nuclei was far greater than. 
that of any other tissue examined. This is not due exclusively 
to the fact that epidermal cells are continuously turning over 
as duodenal enterocytes turn over in much less time. Instead, 
it may reflect the exposure of the epidermis to ultraviolet 
light which can generate free radicals ·and, subsequently, 
produce abasic lesions. Furthermore, the uniform nuclear 
pattern of hAPE antibody staining is not present in enterocytes 
and. epidermal cells solely because they are turning over as non-
replicating cerebellar granular neurons also demonstrate this 
pattern. 
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Autopsy specimens were examined for hAPE expression in the 
brain. Large neurons in the cerebellum, hippocampus, and 
brainstem demonstrated prominent staining of the cytoplasm, and, 
when the nucleus was stained, the hAPE staining corresponded to 
chromatin staining demonstrated by hematoxylin, but sparing the 
nucleoli. Hepatocytes showed a similar staining pattern. Some 
cerebellar granule neuron nuclei and some enterocyte nuclei 
stained uniformly and darkly with both hAPE and hematoxylin 
while epidermal cells demonstrated a uniformly dark nuclear 
pattern with hAPE which did not correspond to the reticular 
staining of chromatin stained with hematoxylin. Another 
intriguing result of these studies was the cell to cell 
differential expression observed in the granule cells of the 
cerebellum. In contrast to the other tissues studied, granule 
cells displayed two strikingly different patterns of hAPE 
expression: numerous cells showed hAPE staining only in the 
cytoplasm while adjacent cells displayed an intense disperse 
nuclear staining. This result indicates a cell to cell 
difference in hAPE . expression or. half-life of the hAPE DNA 
repair mRNA or enzyme in these cells of the cerebellum. This 
was not seen in other brain cells; for example, hippocampal 
neurons all expressed hAPE staining protein primarily in the. 
cytoplasm. This pattern of cell to cell variance, as well as 
the exclusive cytoplasmic staining of hippocampal neurons, 
warrants further investigation. 
the Nissl· substance 
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of hAPE 
hypoglossal 
antibody recognized 
motor neurons. This was a specific reaction as 
there was not staining of Nissl substance when an adjacent 
section was stained with preimrnune rabbi.t imrnunoglobulin (data 
not shown). The Nissl substance represents aggregates of 
ribosomes which are present in the cytoplasm of motor neurons. 
This staining pattern suggests that in these cells hAPE is 
associated with ribosomes and has a previously unrecognized role 
in ribosome function. It is possible that in the other cell 
types that demonstrate cytoplasmic hAPE staining, hAPE is 
associated with ribosomes as well, although this is not apparent 
due to the fact that these cells do not contain the large 
ribosomal aggregates present in motor neurons. 
are interesting in light of previously 
demonstrating that the ribosomal protein 
These results 
published data 
PO is an AP 
endonuclease (Kelley et al., 1989; DeFelice, et al., 1995) as is 
ribosomal protein S3 (Wilson et al., 1994), with the former 
being a class II AP endonuclease and the latter a class I with. 
associated glycosylase activity against 8-oxoguanine (Yacoub et 
al., 1995). Both of these·multifunctional ribosomal/DNA repair 
AP endonucleases have also been found to be associated with the 
nuclear matrix (DeFelice et al., 1995; Wilson et al., 1995). 
The specificity of the imrnunohistochemical reactions 
employed was demonstrated by: a) the cross-reactivity of the 
hAPE antibody to only one protein upon Western blot analysis; 
b) reduced signal after preincubating the primary antibody with 
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purified antigen, and c) the absence of signal when pre-immune 
antibody was used. 
The results of the immunohistochemical survey of human 
tissues also raises many questions. Why do granule cells 0£ the 
cerebellum display such a diverse and cell-to-cell variability 
of hAPE protein expression? 
dentate gyrus expressing 
Why are hippocampal neurons of the 
hAPE protein predominantly in the 
cytoplasm? Why are there different nuclear staining patterns, 
from intense dispersed staining in skin enterocytes, epidermal 
cells, and duodenal cells versus the nuclear rim staining in 
Purkinje cells of the cerebellum or the punctate staining of 
liver nuclei? Why does hAPE protein completely disappear 
approximately 75% of the way out towards the distal tip of villi 
in the duodenum, while other DNA repair proteins are found 
throughout the villi, including the distal tip? Although there 
are various hypotheses for the differing patterns of expression, 
further studies are needed to determine the mechanistic 
principles of the findings presented in this dissertation. 
A consideration that must be addressed when dealing with a 
purported multifunctional protein such as hAPE, concerns whether 
the observed pattern of expression has to do with the DNA repair 
capacity of· the hAPE protein or the alleged redox factor 
function (Walker et al., 1993; Xanthoudakis et al., 1992a; 
Xanthoudakis et al., 1992b; Xanthoudakis et al., 1994). It has 
clearly been shown, in vivo, that the human AP endonuclease 
functions as a DNA repair protein (Demple et al., 1991; ·walker, 
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et al., 1994). Experiments using antisense constructs have 
shown clear cause and effect of lowered levels of hAPE protein 
and cell sensitivity to DNA damaging agents (Walker et al., 
1994). Furthermore, the human AP endonuclease has been shown to 
complement AP endonuclease deficient E. coli cells (Demple et 
al., 1991). Low amounts of protein (picogram amounts) are 
highly active in acting on damaged DNA substrates (Demple et 
al., 1991; Walker et al., 1993; Huq et al., 1995), while 
microgram amounts of AP endonuclease protein are needed for the 
other ascribed activities, and these activities have only been 
demonstrated in in vitro biochemical assays (Demple et al., 
1991; Xanthoudakis et al., 1992b; Xanthoudakis et al., 1994). 
Hypoxic and hyperoxic conditions have been shown to increase 
hAPE protein levels in tissue culture cells, and these results 
have been used to argue for the role of AP endonuclease in 
transcription factor redox activity (Yao et al., 1994), but 
actual in vivo demonstration awaits further studies. 
Furthermore, these studies can as easily be interpreted as an 
indication of enhanced hAPE expression for the repair of 
oxidative lesions following oxygen level alterations (Walker et 
al., 1994). In light of these considerations, it can be 
proposed that the pattern of expression of the hAPE protein 
described here reflects the DNA repair component of the hAPE 
protein. 
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This survey of in vivo cellular and subcellular expression 
of rAPEN mRNA and hAPE protein is the beginning of our· 
understanding of the relationship of DNA BER and cell 
specificity of expression and has yielded several findings not. 
predicted by previous studies using cell lines. These include 
the findings that: 1.) the expression of the manunalian AP 
endonuclease is spatially and temporally regulated; 2.) levels 
of mammalian AP endonuclease expression in brain is higher in 
metabolically active regions, perhaps in response to increased 
incidence of oxidative DNA damage; 3.) the finding that hAPE is 
associated with Nissl substance strongly suggests that hAPE. 
either has functions that are not yet appreciated, or that its 
subcellular pattern of distribution is much more complex than 
initially appreciated using in vitro tissue culture cell lines; 
and 4.) the distinct levels and complex patterns of staining 
between tissues for the hAPE protein clearly suggests that this 
protein has diverse processes of regulation and trafficking in 
the numerous cell and tissue types studied that has not been 
observed during in vitro cell line studies. 
One of the final experiments of this disserta.tion involved 
the examination of wheth~r hAPE expression is modulated by 'the 
cellular process of apoptosis. The apoptotic process is 
important physiologically in that it controls the growth of both 
normal and neoplastic tissues. The myeloid leukemia HL-60 cell 
line has been• well characterized and utilized for studies of 
both apoptosis and cellular differentiation. These cells· can be 
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induced to undergo differentiation and apoptosis in response to 
treatment with retinoic acid (Nagy et al., 1995). A varient of 
the HL-60 cell line that is mutant for the bcl-2 gene, a gene 
involved in blocking the apoptotic signaling pathway, undergoes 
differentiation but not apoptosis (Robertson et al., 1992). 
Therefore, with these two cell lines, HL-60 and HL-60R, it was 
possible to determine the effect of apoptosis and/or 
differentiation on hAPE expression. In the HL-60 cell line, 
hAPE protein levels decreased over a six day period. However, 
in the HL-60R cell line, hAPE levels remained constant. These 
results indicate that hAPE protein levels are reduced by the 
process of apoptosis but remain unaffected by differentiation. 
Interestingly, somewhat different results were obtained for the 
myc gene by Islas and Hanawalt, 1995. These authors observed a 
transcriptional down-regulation of c-myc mRNA levels during 
differentiation of HL-60 cells by TPA (12-0-tetradecanoyl-
phorbol 13-acetate) which induces the cells to undergo 
differentiation but not apoptosis. This down-regulation is due 
to a block of transcriptional elongation and has also been 
ohserved with retinoic acid treatment (Bentley and Groudine, 
1986). The decrease in hAPE protein levels during 
differentiation and apoptosis in HL-60 cells indicates that hAPE 
expression is downregulated by the apoptotic process. However, 
the mechanism of this downregulation has not yet been 
determined. hAPE mRNA levels need to be examined in this model 
system to provide more insight into the process. 
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The final study of this dissertation involved the attempt 
to protect mouse 3T3 fibroblasts from the DNA damaging effects 
of bleomycin. The preliminary results of the dose response 
experiments utilizing the various AP endonuclease expression 
vectors demonstrated that the yeast Apnl AP endonuclease, under 
control of the human phosphoglycerate kinase promoter, is 
capable of providing a nearly three fold decrease in cell 
killing levels after treatment with 100 ug/ml dose of bleomycin. 
The cytotoxic effect of this agent in the induction of pulmonary 
fibrosis has been determined to be through DNA damage (Harrison 
and Lazo, 1987; Lazo and Sebti, 1991). It has been demonstrated 
that "activated" bleomycin reacts with the C-4' position of the 
sugar residue generating a 4'-oxidized AP site along with strand 
breaks (Hecht, 1986). Additionally, 4'-oxidized AP sites have 
been shown to be an excellent substrate for endonuclease IV 
requiring 4-fold lower concentrations of the protein than for 
recognition of regular AP sites while exonuclease III has only 
minor repair activity on this lesion.{HAring et al., 1994). 
Therefore, the ability of the yeast endonuclease IV homologue, 
ApnI, to provide an enhanced survival of 3T3 cells from 
bleomycin is not surprising. The protection of normal cells 
from the cell-killing effects· of bleomycin will significantly 
contribute to the development of therapies for the 
prevention/treatment of bleomycin induced fibrotic lung disease. 
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